<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Ortop (Sao Paulo)</journal-id><journal-id journal-id-type="iso-abbrev">Rev Bras Ortop (Sao Paulo)</journal-id><journal-id journal-id-type="pmc-domain-id">3631</journal-id><journal-id journal-id-type="pmc-domain">rbo</journal-id><journal-title-group><journal-title>Revista Brasileira de Ortopedia</journal-title></journal-title-group><issn pub-type="ppub">0102-3616</issn><issn pub-type="epub">1982-4378</issn><publisher><publisher-name>Sociedade Brasileira de Ortopedia e Traumatologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10038725</article-id><article-id pub-id-type="pmcid-ver">PMC10038725.1</article-id><article-id pub-id-type="pmcaid">10038725</article-id><article-id pub-id-type="pmcaiid">10038725</article-id><article-id pub-id-type="pmid">36969789</article-id><article-id pub-id-type="doi">10.1055/s-0041-1736469</article-id><article-id pub-id-type="publisher-id">2100051pt</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group><subject>Artigo Original</subject><subj-group><subject>Quadril</subject></subj-group></subj-group></article-categories><title-group><article-title xml:lang="en">The Impact of Resident Involvement on Patient Outcomes in Revision Total Hip Arthroplasty</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8338-2806</contrib-id><name name-style="western"><surname>Alexander</surname><given-names initials="B">Bradley</given-names></name><xref rid="AF2100051pt-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0441-5487</contrib-id><name name-style="western"><surname>Sowers</surname><given-names initials="M">Mackenzie</given-names></name><xref rid="AF2100051pt-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3368-7884</contrib-id><name name-style="western"><surname>Jacob</surname><given-names initials="R">Roshan</given-names></name><xref rid="AF2100051pt-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9592-1133</contrib-id><name name-style="western"><surname>McGwin</surname><given-names initials="G">Gerald</given-names></name><xref rid="AF2100051pt-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5327-3702</contrib-id><name name-style="western"><surname>Maffulli</surname><given-names initials="N">Nicola</given-names></name><xref rid="AF2100051pt-3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0538-4528</contrib-id><name name-style="western"><surname>Naranje</surname><given-names initials="S">Sameer</given-names></name><xref rid="AF2100051pt-1" ref-type="aff">1</xref><xref rid="CO2100051pt-1" ref-type="author-notes"/></contrib></contrib-group><aff id="AF2100051pt-1"><label>1</label><institution>Divis&#227;o de Cirurgia Ortop&#233;dica, Universidade do Alabama em Birmingham, Birmingham, Alabama, Estados Unidos</institution></aff><aff id="AF2100051pt-2"><label>2</label><institution>Departamento de Epidemiologia, Universidade do Alabama em Birmingham, Universidade Boulevard Birmingham, Alabama, Estados Unidos</institution></aff><aff id="AF2100051pt-3"><label>3</label><institution>Departamento de Dist&#250;rbios Musculoesquel&#233;ticos, Faculdade de Medicina e Cirurgia, Universidade de Salerno, Baronissi, It&#225;lia</institution></aff><author-notes><corresp id="CO2100051pt-1"><bold>Endere&#231;o para correspond&#234;ncia </bold>Sameer Naranje, MD <institution>Division of Orthopaedic Surgery, University of Alabama at Birmingham</institution><addr-line>1201 11th Ave S #200, Birmingham, AL 35205</addr-line><country>United States</country><email>snaranje@uabmc.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>11</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2023</year></pub-date><volume>58</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">432020</issue-id><fpage>133</fpage><lpage>140</lpage><history><date date-type="received"><day>21</day><month>2</month><year>2021</year></date><date date-type="accepted"><day>02</day><month>9</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>25</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-29 16:25:38.700"><day>29</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>
Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (
<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</uri>
)
</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Sociedade Brasileira de Ortopedia e Traumatologia.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10-1055-s-0041-1736469.pdf"/><abstract><p><bold>Objective</bold>
&#8195;The aim of the present study was to determine the influence of resident involvement on acute complication rates in revision total hip arthroplasty (THA).
</p><p><bold>Methods</bold>
&#8195;Using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, 1,743 revision THAs were identified from 2008 to 2012; 949 of them involved a resident physician. Demographic information including gender and race, comorbidities including lung disease, heart disease and diabetes, operative time, length of stay, and acute postoperative complications within 30 days were analyzed.
</p><p><bold>Results</bold>
&#8195;Resident involvement was not associated with a significant increase in the risk of acute complications. Total operative time demonstrated a statistically significant association with the involvement of a resident (161.35&#8201;minutes with resident present, 135.07&#8201;minutes without resident;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0.001). There was no evidence that resident involvement was associated with a longer hospital stay (5.61 days with resident present, 5.22 days without resident;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.46).
</p><p><bold>Conclusion</bold>
&#8195;Involvement of an orthopedic resident during revision THA does not appear to increase short-term postoperative complication rates, despite a significant increase in operative times.
</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>internship and residency</kwd><kwd>arthroplasty, replacement, hip</kwd><kwd>orthopedic procedures</kwd><kwd>postoperative complications</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>
In 2010, nearly 7 million individuals lived with an artificial hip or knee in the United States.
<xref rid="JR2100051-1" ref-type="bibr">1</xref>
This number is expected to rise as total hip arthroplasty (THA) utilization rates increase secondarily to a rise in the elderly population and life expectancy.
<xref rid="JR2100051-2" ref-type="bibr">2</xref>
By 2030, the demand for primary THA is estimated to reach 572,000 per year, or 174% of the current rate.
<xref rid="JR2100051-3" ref-type="bibr">3</xref>
As the total number of primary THA procedures performed increases, the number of revision surgeries also stands to increase significantly. In one projection, revision THA procedures will increase 2-fold by 2026.
<xref rid="JR2100051-3" ref-type="bibr">3</xref>
</p><p>
If the numbers for both primary and revision THA grow as projected, the estimated number of THA cases will surpass the estimated amount of fellowship-trained arthroplasty surgeons.
<xref rid="JR2100051-3" ref-type="bibr">3</xref>
<xref rid="JR2100051-4" ref-type="bibr">4</xref>
As a result, non-fellowship trained surgeons will experience increased demand to perform primary and revision THA, requiring them to rely on the skills and techniques developed during residency.
<xref rid="JR2100051-5" ref-type="bibr">5</xref>
Therefore, residents must be provided with high-quality training in performing both primary and revision total hip arthroplasty.
</p><p>
Healthcare systems are becoming increasingly more attentive to postoperative morbidity and mortality, as complications may decrease the quality of life of a patient and increase the financial burden on hospitals and healthcare providers.
<xref rid="JR2100051-2" ref-type="bibr">2</xref>
As a result, healthcare systems are implementing quality control initiatives.
<xref rid="JR2100051-6" ref-type="bibr">6</xref>
Residents comprise a large fraction of the healthcare team within academic centers. and quantifying their impact on acute postoperative complications is imperative. In general surgery, considerable amounts of literature have tried to quantify whether resident involvement exerts any detrimental effects on the outcomes of surgical procedures, but studies have varying results.
<xref rid="JR2100051-7" ref-type="bibr">7</xref>
<xref rid="JR2100051-8" ref-type="bibr">8</xref>
<xref rid="JR2100051-9" ref-type="bibr">9</xref>
<xref rid="JR2100051-10" ref-type="bibr">10</xref>
Similar literature for orthopedics is not nearly as vast.
<xref rid="JR2100051-11" ref-type="bibr">11</xref>
<xref rid="JR2100051-12" ref-type="bibr">12</xref>
<xref rid="JR2100051-13" ref-type="bibr">13</xref>
<xref rid="JR2100051-14" ref-type="bibr">14</xref>
<xref rid="JR2100051-15" ref-type="bibr">15</xref>
</p><p>
The objective of the present study was to determine the impact of resident involvement in revision THA using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database.
<xref rid="OR2100051-16" ref-type="bibr">16</xref>
Perioperative and postoperative complication rates for revision THA cases with resident involvement were analyzed to discern whether resident involvement is correlated with poor patient outcomes.
</p></sec><sec><title>Materials and Methods</title><p>The National Surgical Quality Improvement Program (NSQIP) was established in 2012 to help better understand and improve patient outcomes. Clinical information and surgical outcomes were collected from&#8201;&gt;&#8201;400 hospitals in 2012. The variety of hospitals sampled included private, public, academic, and nonacademic hospitals in both urban and rural areas. Patients are followed for 30 days after surgery, and any acute complications, reoperations, or readmissions are recorded. The database is maintained by the American College of Surgeons and the data are collected by a trained surgical clinical reviewer.</p><sec><title>Patient Selection</title><p>
Patients included in the present retrospective observational study had a THA revision defined by the Current Procedural Terminology code 27134 (repair, revision, and/or reconstruction procedures on the pelvis and hip joint) between 2008 and 2012. The NSQIP records resident involvement using the variable &#8220;PGY&#8221; followed by a number (1 to 6), which identifies the year of residency training. The resident surgeon who was scrubbed in and has the highest level of training was recorded. Cases that do not include a resident were recorded with a &#8220;0.&#8221; Resident levels PGY1&#8211;5 were included, while fellows (PGY6) were excluded. In addition, if resident involvement was not indicated, the patient was excluded. The extent of resident participation in the case was not explicitly stated in NSQIP, but the level of training was included. In total, 1,743 patients underwent revision THA and met the inclusion criteria. Of these, 54.4% (
<italic toggle="yes">n</italic>
&#8201;=&#8201;949) were performed with resident involvement.
</p></sec><sec><title>Outcomes</title><p>The acute postoperative complications identified within 30 days include graft/prosthesis/flap failure, surgical site infection, wound dehiscence, reoperation, pneumonia, unplanned intubation, deep vein thrombosis (DVT), pulmonary embolism (PE), ventilation&#8201;&gt;&#8201;48&#8201;hours, renal insufficiency, acute renal failure, urinary tract infection (UTI), stroke/cerebrovascular accident (CVA), peripheral nerve injury, cardiac arrest, and myocardial infarction. Total operative time and length of hospital stay were also analyzed.</p></sec><sec><title>Statistical Analysis</title><p>Preoperative demographic, medical comorbidities and postoperative outcomes were compared between cases with and without resident involvement using the two-sided chi-squared test and the Fisher exact test. Variables related to operative time were adjusted using a multivariable linear regression to remove their potentially confounding influence on the association between operative time and resident involvement. All p-values &#8804; 0.05 were considered statistically significant.</p><p>All statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, North Carolina).</p></sec></sec><sec><title>Results</title><sec><title>Preoperative Characteristics</title><p>
Preoperative characteristics stratified according to resident involvement are shown in
<xref rid="TB2100051en-1" ref-type="table">Table 1</xref>
. Variables showing significance include type of anesthesia (
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0.001), chronic obstructive pulmonary disease (4.64% resident present, 6.93% no resident;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.04), prior operation within 30 days (3.79% resident present, 6.52% no resident;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.01), hypertension requiring medication (55.53% resident present, 63.98% no resident;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0.001), diabetes status (
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.005), and inpatient status (98.10% resident present, 99.37% no resident;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.02).
</p><table-wrap id="TB2100051en-1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Preoperative Demographics and Medical Comorbidities Stratified by Resident Involvement for 1,743 Patients who had a Revision Total Hip Arthroplasty Recorded in the NSQIP Database from 2008&#8211;2012</title></caption><table rules="all"><colgroup align="left" span="4"><col align="left" width="163.55pt" span="1"/><col align="left" width="104.7pt" span="1"/><col align="left" width="104.8pt" span="1"/><col align="left" width="102.7pt" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1"/><th align="left" valign="bottom" colspan="1" rowspan="1">Resident present, %</th><th align="left" valign="bottom" colspan="1" rowspan="1">Resident not present, %</th><th align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">p-value</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Gender</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Female</td><td align="left" valign="top" colspan="1" rowspan="1">54.12</td><td align="left" valign="top" colspan="1" rowspan="1">52.33</td><td align="left" rowspan="2" valign="top" colspan="1">0.46</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Male</td><td align="left" valign="top" colspan="1" rowspan="1">45.88</td><td align="left" valign="top" colspan="1" rowspan="1">47.67</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">ASA Classification</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 1</td><td align="left" valign="top" colspan="1" rowspan="1">1.48</td><td align="left" valign="top" colspan="1" rowspan="1">1.89</td><td align="left" rowspan="5" valign="top" colspan="1">0.51</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 2</td><td align="left" valign="top" colspan="1" rowspan="1">43.20</td><td align="left" valign="top" colspan="1" rowspan="1">39.80</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 3</td><td align="left" valign="top" colspan="1" rowspan="1">50.47</td><td align="left" valign="top" colspan="1" rowspan="1">53.53</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 4</td><td align="left" valign="top" colspan="1" rowspan="1">4.74</td><td align="left" valign="top" colspan="1" rowspan="1">4.79</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 5</td><td align="left" valign="top" colspan="1" rowspan="1">0.11</td><td align="left" valign="top" colspan="1" rowspan="1">0</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Race</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">American Indian or Alaska Native</td><td align="left" valign="top" colspan="1" rowspan="1">0.65</td><td align="left" valign="top" colspan="1" rowspan="1">0.41</td><td align="left" rowspan="5" valign="top" colspan="1">0.78</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Asian</td><td align="left" valign="top" colspan="1" rowspan="1">1.04</td><td align="left" valign="top" colspan="1" rowspan="1">0.55</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Black or African American</td><td align="left" valign="top" colspan="1" rowspan="1">6.61</td><td align="left" valign="top" colspan="1" rowspan="1">6.05</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Native Hawaiian or Pacific Islander</td><td align="left" valign="top" colspan="1" rowspan="1">0.13</td><td align="left" valign="top" colspan="1" rowspan="1">0.14</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">White</td><td align="left" valign="top" colspan="1" rowspan="1">91.58</td><td align="left" valign="top" colspan="1" rowspan="1">92.85</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Anesthesia</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Epidural</td><td align="left" valign="top" colspan="1" rowspan="1">0.21</td><td align="left" valign="top" colspan="1" rowspan="1">1.01</td><td align="left" rowspan="7" valign="top" colspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">General</td><td align="left" valign="top" colspan="1" rowspan="1">74.71</td><td align="left" valign="top" colspan="1" rowspan="1">73.17</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Conscious/Intravenous sedation</td><td align="left" valign="top" colspan="1" rowspan="1">0.53</td><td align="left" valign="top" colspan="1" rowspan="1">0</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Monitored anesthesia care</td><td align="left" valign="top" colspan="1" rowspan="1">0.11</td><td align="left" valign="top" colspan="1" rowspan="1">0.13</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Regional</td><td align="left" valign="top" colspan="1" rowspan="1">8.96</td><td align="left" valign="top" colspan="1" rowspan="1">1.89</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Spinal</td><td align="left" valign="top" colspan="1" rowspan="1">15.28</td><td align="left" valign="top" colspan="1" rowspan="1">23.80</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Unknown</td><td align="left" valign="top" colspan="1" rowspan="1">0.21</td><td align="left" valign="top" colspan="1" rowspan="1">0</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Chronic obstructive pulmonary disease</td><td align="left" valign="top" colspan="1" rowspan="1">4.64</td><td align="left" valign="top" colspan="1" rowspan="1">6.93</td><td align="left" valign="top" colspan="1" rowspan="1">0.04</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Congestive heart failure within 30 days before surgery</td><td align="left" valign="top" colspan="1" rowspan="1">0.74</td><td align="left" valign="top" colspan="1" rowspan="1">0.88</td><td align="left" valign="top" colspan="1" rowspan="1">0.79</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">History of myocardial infarction 6 months prior to surgery</td><td align="left" valign="top" colspan="1" rowspan="1">0.53</td><td align="left" valign="top" colspan="1" rowspan="1">0.26</td><td align="left" valign="top" colspan="1" rowspan="1">0.46</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">History of angina in 1 month before surgery</td><td align="left" valign="top" colspan="1" rowspan="1">0.63</td><td align="left" valign="top" colspan="1" rowspan="1">0.39</td><td align="left" valign="top" colspan="1" rowspan="1">0.52</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Acute renal failure, post-operatively</td><td align="left" valign="top" colspan="1" rowspan="1">0.11</td><td align="left" valign="top" colspan="1" rowspan="1">0.25</td><td align="left" valign="top" colspan="1" rowspan="1">0.59</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Previous percutaneous coronary intervention</td><td align="left" valign="top" colspan="1" rowspan="1">7.17</td><td align="left" valign="top" colspan="1" rowspan="1">7.47</td><td align="left" valign="top" colspan="1" rowspan="1">0.85</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">EtOH&#8201;&gt;&#8201;2 drinks/day in 2 weeks before admission</td><td align="left" valign="top" colspan="1" rowspan="1">4.11</td><td align="left" valign="top" colspan="1" rowspan="1">3.22</td><td align="left" valign="top" colspan="1" rowspan="1">0.37</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Previous cardiac surgery</td><td align="left" valign="top" colspan="1" rowspan="1">6.32</td><td align="left" valign="top" colspan="1" rowspan="1">6.57</td><td align="left" valign="top" colspan="1" rowspan="1">0.84</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">History of revascularization/amputation for peripheral vascular disease</td><td align="left" valign="top" colspan="1" rowspan="1">0.53</td><td align="left" valign="top" colspan="1" rowspan="1">1.29</td><td align="left" valign="top" colspan="1" rowspan="1">0.11</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Currently on dialysis, pre-operatively</td><td align="left" valign="top" colspan="1" rowspan="1">0.32</td><td align="left" valign="top" colspan="1" rowspan="1">0.63</td><td align="left" valign="top" colspan="1" rowspan="1">0.48</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">History of transient ischemic attacks</td><td align="left" valign="top" colspan="1" rowspan="1">3.37</td><td align="left" valign="top" colspan="1" rowspan="1">3.48</td><td align="left" valign="top" colspan="1" rowspan="1">0.89</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cerebrovascular accident/stroke with neurological deficit</td><td align="left" valign="top" colspan="1" rowspan="1">2.32</td><td align="left" valign="top" colspan="1" rowspan="1">2.19</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cerebrovascular accident/stroke with no neurological deficit</td><td align="left" valign="top" colspan="1" rowspan="1">3.07</td><td align="left" valign="top" colspan="1" rowspan="1">3.22</td><td align="left" valign="top" colspan="1" rowspan="1">0.89</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Paraplegia</td><td align="left" valign="top" colspan="1" rowspan="1">0.32</td><td align="left" valign="top" colspan="1" rowspan="1">0.26</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hemiplegia</td><td align="left" valign="top" colspan="1" rowspan="1">0.95</td><td align="left" valign="top" colspan="1" rowspan="1">0.64</td><td align="left" valign="top" colspan="1" rowspan="1">0.59</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Quadriplegia</td><td align="left" valign="top" colspan="1" rowspan="1">0.21</td><td align="left" valign="top" colspan="1" rowspan="1">0</td><td align="left" valign="top" colspan="1" rowspan="1">0.50</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Chemotherapy for malignancy in &#8804; 30 days before revision total hip arthroplasty</td><td align="left" valign="top" colspan="1" rowspan="1">0.53</td><td align="left" valign="top" colspan="1" rowspan="1">0.39</td><td align="left" valign="top" colspan="1" rowspan="1">0.73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Disseminated cancer</td><td align="left" valign="top" colspan="1" rowspan="1">0.42</td><td align="left" valign="top" colspan="1" rowspan="1">1.01</td><td align="left" valign="top" colspan="1" rowspan="1">0.15</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Steroid use for chronic condition</td><td align="left" valign="top" colspan="1" rowspan="1">6.22</td><td align="left" valign="top" colspan="1" rowspan="1">4.53</td><td align="left" valign="top" colspan="1" rowspan="1">0.13</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&gt; 10% loss body weight in last 6 months</td><td align="left" valign="top" colspan="1" rowspan="1">0.63</td><td align="left" valign="top" colspan="1" rowspan="1">1.26</td><td align="left" valign="top" colspan="1" rowspan="1">0.21</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Bleeding disorders</td><td align="left" valign="top" colspan="1" rowspan="1">5.90</td><td align="left" valign="top" colspan="1" rowspan="1">6.05</td><td align="left" valign="top" colspan="1" rowspan="1">0.91</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Prior operation within 30 days</td><td align="left" valign="top" colspan="1" rowspan="1">3.79</td><td align="left" valign="top" colspan="1" rowspan="1">6.52</td><td align="left" valign="top" colspan="1" rowspan="1">0.01</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hypertension requiring medication</td><td align="left" valign="top" colspan="1" rowspan="1">55.53</td><td align="left" valign="top" colspan="1" rowspan="1">63.98</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Current smoker within 1 year</td><td align="left" valign="top" colspan="1" rowspan="1">15.38</td><td align="left" valign="top" colspan="1" rowspan="1">14.74</td><td align="left" valign="top" colspan="1" rowspan="1">0.73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Diabetes Status</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus with insulin</td><td align="left" valign="top" colspan="1" rowspan="1">3.37</td><td align="left" valign="top" colspan="1" rowspan="1">3.78</td><td align="left" rowspan="4" valign="top" colspan="1">0.005</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus without oral agents or insulin</td><td align="left" valign="top" colspan="1" rowspan="1">87.46</td><td align="left" valign="top" colspan="1" rowspan="1">87.15</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus with non-oral and non-insulin agents</td><td align="left" valign="top" colspan="1" rowspan="1">6.95</td><td align="left" valign="top" colspan="1" rowspan="1">4.41</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus with oral agents</td><td align="left" valign="top" colspan="1" rowspan="1">2.21</td><td align="left" valign="top" colspan="1" rowspan="1">4.66</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Functional health status prior to surgery</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Independent</td><td align="left" valign="top" colspan="1" rowspan="1">85.46</td><td align="left" valign="top" colspan="1" rowspan="1">84.13</td><td align="left" rowspan="4" valign="top" colspan="1">0.08</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Partially dependent</td><td align="left" valign="top" colspan="1" rowspan="1">13.49</td><td align="left" valign="top" colspan="1" rowspan="1">13.22</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Totally dependent</td><td align="left" valign="top" colspan="1" rowspan="1">1.05</td><td align="left" valign="top" colspan="1" rowspan="1">2.52</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Unknown</td><td align="left" valign="top" colspan="1" rowspan="1">0</td><td align="left" valign="top" colspan="1" rowspan="1">0.13</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Inpatient</td><td align="left" valign="top" colspan="1" rowspan="1">98.10</td><td align="left" valign="top" colspan="1" rowspan="1">99.37</td><td align="left" valign="top" colspan="1" rowspan="1">0.02</td></tr></tbody></table><table-wrap-foot><fn id="FN2100051en-2"><p>Abbreviation: ASA, American Society of Anesthesiologists.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Total Operative Time and Length of Stay</title><p>
Univariate comparisons of complication rates between revision THA procedures with and without the involvement of a resident are shown in
<xref rid="TB2100051en-2" ref-type="table">Table 2</xref>
. There was a significant increase in total operative time with resident involvement versus without resident involvement (161.35&#8201;minutes resident present, 135.07&#8201;minutes no resident;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0.001). Length of stay (in days) was not significantly increased (5.61 days resident present, 5.22 days no resident;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.46).
</p><table-wrap id="TB2100051en-2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Complication Rates, Length of Stay, and Total Operative Time Stratified by Resident Involvement for 1,743 Patients who had a Revision Total Hip Arthroplasty Recorded in the NSQIP Database from 2008&#8211;2012</title></caption><table rules="all"><colgroup align="left" span="4"><col align="left" width="124.1pt" span="1"/><col align="left" width="114.6pt" span="1"/><col align="left" width="114.65pt" span="1"/><col align="left" width="114.15pt" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1"/><th align="left" valign="bottom" colspan="1" rowspan="1">
Resident present (
<italic toggle="yes">n</italic>
&#8201;=&#8201;949)
</th><th align="left" valign="bottom" colspan="1" rowspan="1">
Resident not present (
<italic toggle="yes">n</italic>
&#8201;=&#8201;794)
</th><th align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">p-value</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Operative time, minutes</td><td align="left" valign="top" colspan="1" rowspan="1">161.35</td><td align="left" valign="top" colspan="1" rowspan="1">135.07</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Length of stay, days</td><td align="left" valign="top" colspan="1" rowspan="1">5.61</td><td align="left" valign="top" colspan="1" rowspan="1">5.22</td><td align="left" valign="top" colspan="1" rowspan="1">0.46</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">
Acute postoperative complications,
<italic toggle="yes">n</italic>
(%)
</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Graft/Prosthesis/Flap Failure</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0.53)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.50)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Superficial infection</td><td align="left" valign="top" colspan="1" rowspan="1">9 (0.95)</td><td align="left" valign="top" colspan="1" rowspan="1">11 (1.39)</td><td align="left" valign="top" colspan="1" rowspan="1">0.49</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Deep infection</td><td align="left" valign="top" colspan="1" rowspan="1">12 (1.26)</td><td align="left" valign="top" colspan="1" rowspan="1">16 (2.02)</td><td align="left" valign="top" colspan="1" rowspan="1">0.25</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Wound dehiscence</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.42)</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0.63)</td><td align="left" valign="top" colspan="1" rowspan="1">0.73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Reoperation</td><td align="left" valign="top" colspan="1" rowspan="1">61 (6.43)</td><td align="left" valign="top" colspan="1" rowspan="1">58 (7.30)</td><td align="left" valign="top" colspan="1" rowspan="1">0.50</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Pneumonia</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.42)</td><td align="left" valign="top" colspan="1" rowspan="1">6 (0.76)</td><td align="left" valign="top" colspan="1" rowspan="1">0.52</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Unplanned intubation</td><td align="left" valign="top" colspan="1" rowspan="1">6 (0.63)</td><td align="left" valign="top" colspan="1" rowspan="1">7 (0.88)</td><td align="left" valign="top" colspan="1" rowspan="1">0.58</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Deep vein thrombosis</td><td align="left" valign="top" colspan="1" rowspan="1">7 (0.74)</td><td align="left" valign="top" colspan="1" rowspan="1">7 (0.88)</td><td align="left" valign="top" colspan="1" rowspan="1">0.79</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Pulmonary embolism</td><td align="left" valign="top" colspan="1" rowspan="1">1 (0.11)</td><td align="left" valign="top" colspan="1" rowspan="1">1 (0.13)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Ventilation&#8201;&gt;&#8201;48 hours</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.42)</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0.63)</td><td align="left" valign="top" colspan="1" rowspan="1">0 0.73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Renal insufficiency</td><td align="left" valign="top" colspan="1" rowspan="1">3 (0.32)</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0.25)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Acute renal failure</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0.21)</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0.25)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Urinary tract infection</td><td align="left" valign="top" colspan="1" rowspan="1">19 (2.00)</td><td align="left" valign="top" colspan="1" rowspan="1">16 (2.02)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0.99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Stroke/Cerebrovascular Accident</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0.21)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.50)</td><td align="left" valign="top" colspan="1" rowspan="1">0.42</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Peripheral nerve injury</td><td align="left" valign="top" colspan="1" rowspan="1">6 (0.63)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.50)</td><td align="left" valign="top" colspan="1" rowspan="1">0.76</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Cardiac arrest</td><td align="left" valign="top" colspan="1" rowspan="1">3 (0.32)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0.50)</td><td align="left" valign="top" colspan="1" rowspan="1">0.70</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Myocardial infarction</td><td align="left" valign="top" colspan="1" rowspan="1">9 (0.95)</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0.63)</td><td align="left" valign="top" colspan="1" rowspan="1">0.59</td></tr></tbody></table></table-wrap></sec><sec><title>Acute Postoperative Complications</title><p>Most complication rates decreased with a resident present, although they did not reach significance.</p></sec><sec><title>Multivariable Regression Model and Risk Factors</title><p>
Significant results from the regression model for operative times are shown in
<xref rid="TB2100051en-3" ref-type="table">Table 3</xref>
. Operative times increased by 28.41&#8201;minutes with resident involvement (
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0.001). Patients identifying as black or African American had longer operation times (+10.79&#8201;minutes;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.02).
</p><table-wrap id="TB2100051en-3" position="float" orientation="portrait"><label>Table 3</label><caption><title>Multivate Regression Analysis with Total Operative Time as the Dependent Variable for 1,743 Patients who had a Revision Total Hip Arthroplasty Recorded in the NSQIP Database from 2008&#8211;2012</title></caption><table rules="all"><colgroup align="left" span="3"><col align="left" width="247.25pt" span="1"/><col align="left" width="112.5pt" span="1"/><col align="left" width="99.35pt" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1">Covariates</th><th align="left" valign="bottom" colspan="1" rowspan="1">Change in operative time, minutes</th><th align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">p-value</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Gender &#8211; Female</td><td align="left" valign="top" colspan="1" rowspan="1">- 11.13</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">ASA Classification 1</td><td align="left" valign="top" colspan="1" rowspan="1">- 23.96</td><td align="left" valign="top" colspan="1" rowspan="1">0.03</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">ASA Classification 2</td><td align="left" valign="top" colspan="1" rowspan="1">- 9.44</td><td align="left" valign="top" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Race &#8211; Black or African American</td><td align="left" valign="top" colspan="1" rowspan="1">10.79</td><td align="left" valign="top" colspan="1" rowspan="1">0.02</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Anesthesia &#8211; Regional</td><td align="left" valign="top" colspan="1" rowspan="1">- 38.47</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Anesthesia &#8211; Spinal</td><td align="left" valign="top" colspan="1" rowspan="1">- 19.947</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Previous percutaneous coronary intervention &#8211; Yes</td><td align="left" valign="top" colspan="1" rowspan="1">- 10.093</td><td align="left" valign="top" colspan="1" rowspan="1">0.03</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Prior operation within 30 days &#8211; Yes</td><td align="left" valign="top" colspan="1" rowspan="1">- 23.460</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Current smoker within 1 year &#8211; Yes</td><td align="left" valign="top" colspan="1" rowspan="1">- 9.958</td><td align="left" valign="top" colspan="1" rowspan="1">0.01</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Outpatient</td><td align="left" valign="top" colspan="1" rowspan="1">- 40.224</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Resident present</td><td align="left" valign="top" colspan="1" rowspan="1">28.412</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0.001</td></tr></tbody></table><table-wrap-foot><fn id="FN2100051en-3"><p>Abbreviation; ASA, American Society of Anesthesiologists.</p></fn></table-wrap-foot></table-wrap><p>
Variables showing shorter operative times included female patients, an ASA classification of 1 or 2, previous percutaneous coronary intervention (PCI), prior operation within 30 days of THA, being an active smoker, and outpatient status. Surgeries that used spinal or regional anesthesia were significantly shorter than surgeries using the other anesthesia types. (- 19.94&#8201;minutes and - 38.471&#8201;minutes, respectively;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0.001 for both).
</p></sec><sec><title>Power Analysis</title><p>For all the comparisons except operating room time, the power is&#8201;&lt;&#8201;10%. The power for operating room time is 99%.</p></sec></sec><sec><title>Discussion</title><p>Resident involvement in revision total hip arthroplasty does not significantly increase acute postoperative complications within 30 days. This large national database study of 1,743 cases found that operative time increased an average of 28.41&#8201;minutes. Despite this increase in operation time, the number of acute postoperative complications was low in both patient cohorts. This highlights the general safety and efficacy of revision hip arthroplasty procedures. The increase in operative time seen with resident participation did not lead to an associated increase in superficial infections (0.95 versus 1.39%), deep infections (0.46 versus 0.93%), or wound dehiscence (0.42 versus 0.63%).</p><p>
The numbers of both primary and revision THA cases are expected to surpass the estimated number of total fellowship-trained joint surgeons.
<xref rid="JR2100051-4" ref-type="bibr">4</xref>
As this occurs, non-fellowship trained orthopedic surgeons will be encouraged to shoulder the extra demand, if they are adequately trained, highlighting the value of involving residents in revision hip arthroplasty cases. It is important, then, to understand the impact they have on patient outcomes. Residents do not influence complication rates in primary THA,
<xref rid="JR2100051-5" ref-type="bibr">5</xref>
<xref rid="JR2100051-15" ref-type="bibr">15</xref>
but revision THA is more complex and presents different challenges with new opportunities for complications.
</p><sec><title>Previous Studies on Resident Involvement</title><p>
Major morbidity did not rise with resident involvement in 66,817 cases involving 6 different orthopedic procedures (stratifying for the severity of morbidity).
<xref rid="JR2100051-17" ref-type="bibr">17</xref>
The influence of residents on minor morbidity, however, is difficult to isolate because of the high disease burden in patients and of the involvement of numerous staff postoperatively. The NSQIP data from 2005 to 2010 revealed that residents significantly increase the risk of &#8805; 1 postoperative complications or major systemic complications in total knee and hip joint arthroplasty.
<xref rid="JR2100051-11" ref-type="bibr">11</xref>
This study did not stratify total knee and THA cases into separate cohorts. In contrast, a second study revealed that residents do not influence complications in primary THA cases, but revision surgeries were excluded in the analysis (NSQIP data from 2012).
<xref rid="JR2100051-5" ref-type="bibr">5</xref>
Since revision THAs are more demanding procedures, data limited to primary THA procedures fail to accurately categorize resident involvement in revisions.
<xref rid="JR2100051-18" ref-type="bibr">18</xref>
<xref rid="JR2100051-19" ref-type="bibr">19</xref>
<xref rid="JR2100051-20" ref-type="bibr">20</xref>
The present study did not evidence an increase in major or minor complications with the involvement of residents during revision THA cases.
</p></sec><sec><title>Challenges of Revision THA</title><p>
Primary THAs reliably reduce pain and increase functional status for patients with end-stage osteoarthritis. Through early operative intervention, patients can achieve excellent outcomes, and the rate of revision surgery remains low at 6% at 5 years and 12% at 10 years.
<xref rid="JR2100051-21" ref-type="bibr">21</xref>
<xref rid="JR2100051-22" ref-type="bibr">22</xref>
Despite the high success rates and benefits of primary THA, dislocation and infection may still lead to implant failure and revision.
<xref rid="JR2100051-4" ref-type="bibr">4</xref>
The distorted anatomy and complications associated with primary THA can create unique challenges for orthopedic surgeons during revision.
<xref rid="JR2100051-20" ref-type="bibr">20</xref>
<xref rid="JR2100051-23" ref-type="bibr">23</xref>
<xref rid="JR2100051-24" ref-type="bibr">24</xref>
These challenges can lead to an increased mortality, infection, and dislocation rates postoperatively in revision cases compared with primary THA.
<xref rid="JR2100051-25" ref-type="bibr">25</xref>
Furthermore, patients undergoing revision THA have bone and soft tissue damage around the hip, which compromises the joint and often inhibits the use of standard primary implants.
<xref rid="JR2100051-20" ref-type="bibr">20</xref>
<xref rid="JR2100051-23" ref-type="bibr">23</xref>
<xref rid="JR2100051-24" ref-type="bibr">24</xref>
It is crucial that surgeons are trained and competent when using specific implants designed to work effectively under poor conditions.
</p></sec><sec><title>Effects of Resident Involvement</title><p>
The present study showed that complication rates such as reoperation, DVT, and unplanned intubation decreased with residents involved in revision THA. The most common cause of failure for revision THA, infection (including superficial infections, deep infections, and wound dehiscence),
<xref rid="JR2100051-26" ref-type="bibr">26</xref>
declined when residents were involved. Furthermore, the involvement of residents can help to increase their confidence and preparedness as they progress through their career.
<xref rid="JR2100051-27" ref-type="bibr">27</xref>
</p><p>
Despite complication rates not increasing significantly with resident involvement, there was a significant increase in operative time with resident involvement. This may stem from the challenge of teaching trainees on complicated anatomy, especially seen in patients with higher rates of comorbidities. This finding has been previously highlighted in general surgery and other surgical specialties.
<xref rid="JR2100051-28" ref-type="bibr">28</xref>
<xref rid="JR2100051-29" ref-type="bibr">29</xref>
Although increases in operation time do increase the risk of infection in primary joint arthroplasty,
<xref rid="JR2100051-30" ref-type="bibr">30</xref>
the involvement of residents did not result in increased infections.
</p><p>As expected, lower risk patients with less comorbidities, ASA classifications 1 and 2 and outpatient procedures, were associated with significantly shorter operation times. The use of spinal and regional anesthesia, rather than general anesthesia, was also associated with shorter operative times. Less expectedly, females, patients with a history of previous PCI, prior operation within 30 days, and smoking also experienced significantly shorter operative times.</p></sec><sec><title>Strengths and Limitations</title><p>The present study utilized the NSQIP database. This is a large database that allows access to a large, multicentered, multiregional sample of revision THA procedures that specifically notate resident involvement. However, using this database comes with drawbacks. Extrapolating data from multiple medical centers across the United States lends itself to a nonstandardized method of reporting data. There is no marker quantifying the degree of resident involvement or case complexity. The data was collected by a trained surgical reviewer. Neither the relative involvement of the resident or of the attending surgeon in the surgical steps was quantified in the data records. It is not possible to isolate the involvement of orthopedic residents, while controlling for other resident involvement in patient care. The database only collects outcomes within 30 days of surgery, so other long-term outcomes are not recorded. Additionally, a power analysis was not completed to ensure adequate sample size.</p><p>Despite these limitations, this is the largest study that evaluates the impact of resident involvement on acute postoperative complications for revision THA. A total of 1,743 revision THAs were evaluated, with 949 of those involving resident physicians. In the future, additional large, multicentered, prospective studies about resident involvement could support the results of the present study.</p></sec></sec><sec><title>Conclusions</title><p>Overall, the present study showed that resident involvement in revision THA did not significantly impact outcomes including morbidity, mortality, and complication rates. Resident participation is associated with significantly increased operative time, but this did not translate into an increase in infection rate. Based upon these results, residents should continue to be involved in the surgical management of revision THA patients.</p></sec></body><back><fn-group><fn fn-type="COI-statement" id="d35e129"><p><bold>Conflito de Interesses</bold> Os autores n&#227;o possuem conflitos de interesses a declarar.</p></fn></fn-group><fn-group xml:lang="pt"><title>Aprova&#231;&#227;o &#201;tica</title><fn id="FN2100051pt-3"><p>A aprova&#231;&#227;o do IRB n&#227;o foi necess&#225;ria, uma vez que esses dados foram obtidos a partir de um banco de dados nacional n&#227;o identificado.</p></fn></fn-group><fn-group xml:lang="en"><title>Ethical Approval</title><fn id="FN2100051en-4"><p>IRB approval was not necessary given that these data were obtained from a de-identified national database.</p></fn></fn-group><fn-group xml:lang="pt"><title>Isen&#231;&#227;o de responsabilidade ACS NSQIP</title><fn id="FN2100051pt-4"><p>O Programa Nacional de Melhoria da Qualidade Cir&#250;rgica do Col&#233;gio Americano de Cirurgi&#245;es e os hospitais participantes do ACS NSQIP s&#227;o a fonte dos dados aqui utilizados; n&#227;o verificaram e n&#227;o se responsabilizam pela validade estat&#237;stica da an&#225;lise dos dados ou pelas conclus&#245;es derivadas dos autores.</p></fn></fn-group><fn-group xml:lang="en"><title>ACS NSQIP Disclaimer</title><fn id="FN2100051en-5"><p>The American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating in the ACS NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or for the conclusions derived by the authors.</p></fn></fn-group><fn-group xml:lang="pt"><title>Suporte Financeiro</title><fn id="FN2100051pt-5"><p>A presente pesquisa n&#227;o recebeu nenhuma subven&#231;&#227;o espec&#237;fica de ag&#234;ncias de fomenta&#231;&#227;o nos setores p&#250;blico, comercial ou sem fins lucrativos.</p></fn></fn-group><fn-group xml:lang="en"><title>Financial Support</title><fn id="FN2100051en-6"><p>The present research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></fn></fn-group><fn-group xml:lang="pt"><fn id="FN2100051pt-1"><p>
<italic toggle="yes">Trabalho desenvolvido na Divis&#227;o de Cirurgia Ortop&#233;dica, Universidade do Alabama em Birmingham, Birmingham, Alabama, Estados Unidos da Am&#233;rica.</italic>
</p></fn></fn-group><fn-group xml:lang="en"><fn id="FN2100051en-1"><p>
<italic toggle="yes">Work developed at the Division of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</italic>
</p></fn></fn-group><ref-list><title>Refer&#234;ncias</title><ref id="JR2100051-1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maradit Kremers</surname><given-names>H</given-names></name><name name-style="western"><surname>Larson</surname><given-names>D R</given-names></name><name name-style="western"><surname>Crowson</surname><given-names>C S</given-names></name></person-group><etal/><article-title>Prevalence of Total Hip and Knee Replacement in the United States</article-title><source>J Bone Joint Surg Am</source><year>2015</year><volume>97</volume><issue>17</issue><fpage>1386</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">26333733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.N.01141</pub-id><pub-id pub-id-type="pmcid">PMC4551172</pub-id></mixed-citation></ref><ref id="JR2100051-2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>M</given-names></name><name name-style="western"><surname>Della Valle</surname><given-names>C J</given-names></name><name name-style="western"><surname>Jacofsky</surname><given-names>D J</given-names></name><name name-style="western"><surname>Meneghini</surname><given-names>R M</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>F S</given-names></name></person-group><article-title>Early postoperative complications after total hip arthroplasty: current strategies for prevention and treatment</article-title><source>Instr Course Lect</source><year>2015</year><volume>64</volume><fpage>337</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">25745918</pub-id></mixed-citation></ref><ref id="JR2100051-3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurtz</surname><given-names>S</given-names></name><name name-style="western"><surname>Ong</surname><given-names>K</given-names></name><name name-style="western"><surname>Lau</surname><given-names>E</given-names></name><name name-style="western"><surname>Mowat</surname><given-names>F</given-names></name><name name-style="western"><surname>Halpern</surname><given-names>M</given-names></name></person-group><article-title>Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030</article-title><source>J Bone Joint Surg Am</source><year>2007</year><volume>89</volume><issue>04</issue><fpage>780</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">17403800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.F.00222</pub-id></mixed-citation></ref><ref id="JR2100051-4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gwam</surname><given-names>C U</given-names></name><name name-style="western"><surname>Mistry</surname><given-names>J B</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>N S</given-names></name></person-group><etal/><article-title>Current Epidemiology of Revision Total Hip Arthroplasty in the United States: National Inpatient Sample 2009 to 2013</article-title><source>J Arthroplasty</source><year>2017</year><volume>32</volume><issue>07</issue><fpage>2088</fpage><lpage>2092</lpage><pub-id pub-id-type="pmid">28336249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2017.02.046</pub-id></mixed-citation></ref><ref id="JR2100051-5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haughom</surname><given-names>B D</given-names></name><name name-style="western"><surname>Schairer</surname><given-names>W W</given-names></name><name name-style="western"><surname>Hellman</surname><given-names>M D</given-names></name><name name-style="western"><surname>Yi</surname><given-names>P H</given-names></name><name name-style="western"><surname>Levine</surname><given-names>B R</given-names></name></person-group><article-title>Does resident involvement impact post-operative complications following primary total knee arthroplasty? An analysis of 24,529 cases</article-title><source>J Arthroplasty</source><year>2014</year><volume>29</volume><issue>07</issue><fpage>1468</fpage><lpage>147200</lpage><pub-id pub-id-type="pmid">24726182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2014.02.036</pub-id></mixed-citation></ref><ref id="JR2100051-6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lohse</surname><given-names>G R</given-names></name><name name-style="western"><surname>Leopold</surname><given-names>S S</given-names></name><name name-style="western"><surname>Theiler</surname><given-names>S</given-names></name><name name-style="western"><surname>Sayre</surname><given-names>C</given-names></name><name name-style="western"><surname>Cizik</surname><given-names>A</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M J</given-names></name></person-group><article-title>Systems-based safety intervention: reducing falls with injury and total falls on an orthopaedic ward</article-title><source>J Bone Joint Surg Am</source><year>2012</year><volume>94</volume><issue>13</issue><fpage>1217</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">22760390</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.J.01647</pub-id></mixed-citation></ref><ref id="JR2100051-7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>S S</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Husain</surname><given-names>F A</given-names></name><name name-style="western"><surname>Lin</surname><given-names>E</given-names></name><name name-style="western"><surname>Nandipati</surname><given-names>K C</given-names></name><name name-style="western"><surname>Perez</surname><given-names>S</given-names></name><name name-style="western"><surname>Sweeney</surname><given-names>J F</given-names></name></person-group><article-title>Resident participation in index laparoscopic general surgical cases: impact of the learning environment on surgical outcomes</article-title><source>J Am Coll Surg</source><year>2013</year><volume>216</volume><issue>01</issue><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">22999330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamcollsurg.2012.08.014</pub-id></mixed-citation></ref><ref id="JR2100051-8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raval</surname><given-names>M V</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>M E</given-names></name></person-group><etal/><article-title>The influence of resident involvement on surgical outcomes</article-title><source>J Am Coll Surg</source><year>2011</year><volume>212</volume><issue>05</issue><fpage>889</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">21398151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamcollsurg.2010.12.029</pub-id></mixed-citation></ref><ref id="JR2100051-9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiran</surname><given-names>R P</given-names></name><name name-style="western"><surname>Ahmed Ali</surname><given-names>U</given-names></name><name name-style="western"><surname>Coffey</surname><given-names>J C</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>J D</given-names></name><name name-style="western"><surname>Pokala</surname><given-names>N</given-names></name><name name-style="western"><surname>Fazio</surname><given-names>V W</given-names></name></person-group><article-title>Impact of resident participation in surgical operations on postoperative outcomes: National Surgical Quality Improvement Program</article-title><source>Ann Surg</source><year>2012</year><volume>256</volume><issue>03</issue><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">22842127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLA.0b013e318265812a</pub-id></mixed-citation></ref><ref id="JR2100051-10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kazaure</surname><given-names>H S</given-names></name><name name-style="western"><surname>Roman</surname><given-names>S A</given-names></name><name name-style="western"><surname>Sosa</surname><given-names>J A</given-names></name></person-group><article-title>The resident as surgeon: an analysis of ACS-NSQIP</article-title><source>J Surg Res</source><year>2012</year><volume>178</volume><issue>01</issue><fpage>126</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">22445454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jss.2011.12.033</pub-id></mixed-citation></ref><ref id="JR2100051-11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schoenfeld</surname><given-names>A J</given-names></name><name name-style="western"><surname>Serrano</surname><given-names>J A</given-names></name><name name-style="western"><surname>Waterman</surname><given-names>B R</given-names></name><name name-style="western"><surname>Bader</surname><given-names>J O</given-names></name><name name-style="western"><surname>Belmont</surname><given-names>P J</given-names><suffix>Jr</suffix></name></person-group><article-title>The impact of resident involvement on post-operative morbidity and mortality following orthopaedic procedures: a study of 43,343 cases</article-title><source>Arch Orthop Trauma Surg</source><year>2013</year><volume>133</volume><issue>11</issue><fpage>1483</fpage><lpage>1491</lpage><pub-id pub-id-type="pmid">23995548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00402-013-1841-3</pub-id></mixed-citation></ref><ref id="JR2100051-12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auerbach</surname><given-names>J D</given-names></name><name name-style="western"><surname>Lonner</surname><given-names>B S</given-names></name><name name-style="western"><surname>Antonacci</surname><given-names>M D</given-names></name><name name-style="western"><surname>Kean</surname><given-names>K E</given-names></name></person-group><article-title>Perioperative outcomes and complications related to teaching residents and fellows in scoliosis surgery</article-title><source>Spine (Phila Pa 1976)</source><year>2008</year><volume>33</volume><issue>10</issue><fpage>1113</fpage><lpage>1118</lpage><pub-id pub-id-type="pmid">18449046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/BRS.0b013e31816f69cf</pub-id></mixed-citation></ref><ref id="JR2100051-13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavernia</surname><given-names>C J</given-names></name><name name-style="western"><surname>Sierra</surname><given-names>R J</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>R A</given-names></name></person-group><article-title>The cost of teaching total knee arthroplasty surgery to orthopaedic surgery residents</article-title><source>Clin Orthop Relat Res</source><year>2000</year><issue>380</issue><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00003086-200011000-00014</pub-id><pub-id pub-id-type="pmid">11064979</pub-id></mixed-citation></ref><ref id="JR2100051-14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woolson</surname><given-names>S T</given-names></name><name name-style="western"><surname>Kang</surname><given-names>M N</given-names></name></person-group><article-title>A comparison of the results of total hip and knee arthroplasty performed on a teaching service or a private practice service</article-title><source>J Bone Joint Surg Am</source><year>2007</year><volume>89</volume><issue>03</issue><fpage>601</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">17332109</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.F.00584</pub-id></mixed-citation></ref><ref id="JR2100051-15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giordano</surname><given-names>L</given-names></name><name name-style="western"><surname>Oliviero</surname><given-names>A</given-names></name><name name-style="western"><surname>Peretti</surname><given-names>G M</given-names></name><name name-style="western"><surname>Maffulli</surname><given-names>N</given-names></name></person-group><article-title>The presence of residents during orthopedic operation exerts no negative influence on outcome</article-title><source>Br Med Bull</source><year>2019</year><volume>130</volume><issue>01</issue><fpage>65</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">31049559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bmb/ldz009</pub-id></mixed-citation></ref><ref id="OR2100051-16"><label>16</label><mixed-citation publication-type="other"><collab>ACS NSQIP&#174; </collab><article-title>Surgical Risk Calculator</article-title>Available online:<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://riskcalculator.facs.org/">http://riskcalculator.facs.org/</uri></mixed-citation></ref><ref id="JR2100051-17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pugely</surname><given-names>A J</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C T</given-names></name><name name-style="western"><surname>Callagh</surname><given-names>J J</given-names></name><name name-style="western"><surname>Weinstein</surname><given-names>S L</given-names></name><name name-style="western"><surname>Marsh</surname><given-names>J L</given-names></name></person-group><article-title>The effect of resident participation on short-term outcomes after orthopaedic surgery</article-title><source>Clin Orthop Relat Res</source><year>2014</year><volume>472</volume><issue>07</issue><fpage>2290</fpage><lpage>2300</lpage><pub-id pub-id-type="pmid">24658902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-014-3567-0</pub-id><pub-id pub-id-type="pmcid">PMC4048420</pub-id></mixed-citation></ref><ref id="JR2100051-18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>J N</given-names></name><name name-style="western"><surname>Wright</surname><given-names>E A</given-names></name><name name-style="western"><surname>Wright</surname><given-names>J</given-names></name></person-group><etal/><article-title>Twelve-year risk of revision after primary total hip replacement in the U.S. Medicare population</article-title><source>J Bone Joint Surg Am</source><year>2012</year><volume>94</volume><issue>20</issue><fpage>1825</fpage><lpage>1832</lpage><pub-id pub-id-type="pmid">23079874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.K.00569</pub-id><pub-id pub-id-type="pmcid">PMC3489069</pub-id></mixed-citation></ref><ref id="JR2100051-19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kotwal</surname><given-names>R S</given-names></name><name name-style="western"><surname>Ganapathi</surname><given-names>M</given-names></name><name name-style="western"><surname>John</surname><given-names>A</given-names></name><name name-style="western"><surname>Maheson</surname><given-names>M</given-names></name><name name-style="western"><surname>Jones</surname><given-names>S A</given-names></name></person-group><article-title>Outcome of treatment for dislocation after primary total hip replacement</article-title><source>J Bone Joint Surg Br</source><year>2009</year><volume>91</volume><issue>03</issue><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">19258606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620X.91B3.21274</pub-id></mixed-citation></ref><ref id="JR2100051-20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ong</surname><given-names>K L</given-names></name><name name-style="western"><surname>Lau</surname><given-names>E</given-names></name><name name-style="western"><surname>Suggs</surname><given-names>J</given-names></name><name name-style="western"><surname>Kurtz</surname><given-names>S M</given-names></name><name name-style="western"><surname>Manley</surname><given-names>M T</given-names></name></person-group><article-title>Risk of subsequent revision after primary and revision total joint arthroplasty</article-title><source>Clin Orthop Relat Res</source><year>2010</year><volume>468</volume><issue>11</issue><fpage>3070</fpage><lpage>3076</lpage><pub-id pub-id-type="pmid">20499292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-010-1399-0</pub-id><pub-id pub-id-type="pmcid">PMC2947702</pub-id></mixed-citation></ref><ref id="JR2100051-21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holtzman</surname><given-names>J</given-names></name><name name-style="western"><surname>Saleh</surname><given-names>K</given-names></name><name name-style="western"><surname>Kane</surname><given-names>R</given-names></name></person-group><article-title>Effect of baseline functional status and pain on outcomes of total hip arthroplasty</article-title><source>J Bone Joint Surg Am</source><year>2002</year><volume>84</volume><issue>11</issue><fpage>1942</fpage><lpage>1948</lpage><pub-id pub-id-type="pmid">12429753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/00004623-200211000-00006</pub-id></mixed-citation></ref><ref id="JR2100051-22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labek</surname><given-names>G</given-names></name><name name-style="western"><surname>Thaler</surname><given-names>M</given-names></name><name name-style="western"><surname>Janda</surname><given-names>W</given-names></name><name name-style="western"><surname>Agreiter</surname><given-names>M</given-names></name><name name-style="western"><surname>St&#246;ckl</surname><given-names>B</given-names></name></person-group><article-title>Revision rates after total joint replacement: cumulative results from worldwide joint register datasets</article-title><source>J Bone Joint Surg Br</source><year>2011</year><volume>93</volume><issue>03</issue><fpage>293</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">21357948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620X.93B3.25467</pub-id></mixed-citation></ref><ref id="JR2100051-23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottle</surname><given-names>A</given-names></name><name name-style="western"><surname>Parikh</surname><given-names>S</given-names></name><name name-style="western"><surname>Aylin</surname><given-names>P</given-names></name><name name-style="western"><surname>Loeffler</surname><given-names>M</given-names></name></person-group><article-title>Risk factors for early revision after total hip and knee arthroplasty: National observational study from a surgeon and population perspective</article-title><source>PLoS One</source><year>2019</year><volume>14</volume><issue>04</issue><fpage>e0214855</fpage><pub-id pub-id-type="pmid">30964880</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0214855</pub-id><pub-id pub-id-type="pmcid">PMC6456180</pub-id></mixed-citation></ref><ref id="JR2100051-24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lachiewicz</surname><given-names>P F</given-names></name><name name-style="western"><surname>Soileau</surname><given-names>E S</given-names></name></person-group><article-title>Changing indications for revision total hip arthroplasty</article-title><source>J Surg Orthop Adv</source><year>2005</year><volume>14</volume><issue>02</issue><fpage>82</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16115433</pub-id></mixed-citation></ref><ref id="JR2100051-25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahomed</surname><given-names>N N</given-names></name><name name-style="western"><surname>Barrett</surname><given-names>J A</given-names></name><name name-style="western"><surname>Katz</surname><given-names>J N</given-names></name></person-group><etal/><article-title>Rates and outcomes of primary and revision total hip replacement in the United States medicare population</article-title><source>J Bone Joint Surg Am</source><year>2003</year><volume>85</volume><issue>01</issue><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">12533568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/00004623-200301000-00005</pub-id></mixed-citation></ref><ref id="JR2100051-26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jafari</surname><given-names>S M</given-names></name><name name-style="western"><surname>Coyle</surname><given-names>C</given-names></name><name name-style="western"><surname>Mortazavi</surname><given-names>S M</given-names></name><name name-style="western"><surname>Sharkey</surname><given-names>P F</given-names></name><name name-style="western"><surname>Parvizi</surname><given-names>J</given-names></name></person-group><article-title>Revision hip arthroplasty: infection is the most common cause of failure</article-title><source>Clin Orthop Relat Res</source><year>2010</year><volume>468</volume><issue>08</issue><fpage>2046</fpage><lpage>2051</lpage><pub-id pub-id-type="pmid">20195808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-010-1251-6</pub-id><pub-id pub-id-type="pmcid">PMC2895846</pub-id></mixed-citation></ref><ref id="JR2100051-27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>J D</given-names></name><name name-style="western"><surname>Staheli</surname><given-names>G</given-names></name><name name-style="western"><surname>LeClere</surname><given-names>L</given-names></name><name name-style="western"><surname>Andersone</surname><given-names>D</given-names></name><name name-style="western"><surname>McCormick</surname><given-names>F</given-names></name></person-group><article-title>What effects have resident work-hour changes had on education, quality of life, and safety? A systematic review</article-title><source>Clin Orthop Relat Res</source><year>2015</year><volume>473</volume><issue>05</issue><fpage>1600</fpage><lpage>1608</lpage><pub-id pub-id-type="pmid">25269530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-014-3968-0</pub-id><pub-id pub-id-type="pmcid">PMC4385350</pub-id></mixed-citation></ref><ref id="JR2100051-28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coates</surname><given-names>K W</given-names></name><name name-style="western"><surname>Kuehl</surname><given-names>T J</given-names></name><name name-style="western"><surname>Bachofen</surname><given-names>C G</given-names></name><name name-style="western"><surname>Shull</surname><given-names>B L</given-names></name></person-group><article-title>Analysis of surgical complications and patient outcomes in a residency training program</article-title><source>Am J Obstet Gynecol</source><year>2001</year><volume>184</volume><issue>07</issue><fpage>1380</fpage><lpage>1383</lpage>, discussion 1383&#8211;1385<pub-id pub-id-type="pmid">11408856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mob.2001.115045</pub-id></mixed-citation></ref><ref id="JR2100051-29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papandria</surname><given-names>D</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>D</given-names></name><name name-style="western"><surname>Ortega</surname><given-names>G</given-names></name></person-group><etal/><article-title>Assessing trainee impact on operative time for common general surgical procedures in ACS-NSQIP</article-title><source>J Surg Educ</source><year>2012</year><volume>69</volume><issue>02</issue><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">22365858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsurg.2011.08.003</pub-id></mixed-citation></ref><ref id="JR2100051-30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Goswami</surname><given-names>K</given-names></name><name name-style="western"><surname>Shohat</surname><given-names>N</given-names></name><name name-style="western"><surname>Aalirezaie</surname><given-names>A</given-names></name><name name-style="western"><surname>Manrique</surname><given-names>J</given-names></name><name name-style="western"><surname>Parvizi</surname><given-names>J</given-names></name></person-group><article-title>Longer Operative Time Results in a Higher Rate of Subsequent Periprosthetic Joint Infection in Patients Undergoing Primary Joint Arthroplasty</article-title><source>J Arthroplasty</source><year>2019</year><volume>34</volume><issue>05</issue><fpage>947</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">30765229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2019.01.027</pub-id></mixed-citation></ref></ref-list></back><sub-article id="s1" article-type="research-article" xml:lang="pt"><front-stub><title-group><article-title xml:lang="pt">O impacto do envolvimento do residente nos resultados dos pacientes na revis&#227;o da artroplastia total do quadril</article-title></title-group><abstract><title>Resumo</title><p><bold>Objetivo</bold>
&#8195;O objetivo do presente estudo foi determinar a influ&#234;ncia do envolvimento dos residentes nas taxas de complica&#231;&#245;es agudas na revis&#227;o da artroplastia total do quadril (ATQ).
</p><p><bold>M&#233;todos</bold>
&#8195;Utilizando o banco de dados do American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP, na sigla em ingl&#234;s), foram identificadas 1.743 revis&#245;es de ATQs entre 2008 e 2012; 949 delas envolveram um m&#233;dico residente. Foram analisadas informa&#231;&#245;es demogr&#225;ficas, incluindo g&#234;nero e ra&#231;a, comorbidades, incluindo doen&#231;as pulmonares, doen&#231;as card&#237;acas e diabetes, tempo de perman&#234;ncia e complica&#231;&#245;es agudas p&#243;s-operat&#243;rias no prazo de 30 dias.
</p><p><bold>Resultados</bold>
&#8195;O envolvimento dos residentes n&#227;o foi associado a um aumento significativo no risco de complica&#231;&#245;es agudas. O tempo de opera&#231;&#227;o total demonstrou associa&#231;&#227;o estatisticamente significativa com o envolvimento de um residente (161,35 minutos com residente presente, 135,07 minutos sem residente;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0,001). N&#227;o houve evid&#234;ncia de que o envolvimento do residente tenha sido associado a um maior tempo de interna&#231;&#227;o hospitalar (5,61 dias com residente presente, 5,22 dias sem residente;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,46).
</p><p><bold>Conclus&#227;o</bold>
&#8195;O envolvimento de um residente ortop&#233;dico durante a revis&#227;o da ATQ n&#227;o parece aumentar as taxas de complica&#231;&#245;es p&#243;s-operat&#243;rias de curto prazo, apesar de um aumento significativo nos tempos operacionais.
</p></abstract><kwd-group xml:lang="pt"><title>Palavras-chave</title><kwd>internato e resid&#234;ncia</kwd><kwd>artroplastia de quadril</kwd><kwd>procedimentos ortop&#233;dicos</kwd><kwd>complica&#231;&#245;es p&#243;s-operat&#243;rias</kwd></kwd-group></front-stub><body><sec><title>Introdu&#231;&#227;o</title><p>
Em 2010, quase 7 milh&#245;es de pessoas viviam com um quadril ou joelho artificial nos Estados Unidos.
<xref rid="JR2100051-1" ref-type="bibr">1</xref>
Espera-se que este n&#250;mero aumente &#224; medida que as taxas totais de utiliza&#231;&#227;o da artroplastia do quadril (ATQ) aumentam em consequ&#234;ncia do aumento da popula&#231;&#227;o idosa e da expectativa de vida.
<xref rid="JR2100051-2" ref-type="bibr">2</xref>
At&#233; 2030, a demanda por ATQ prim&#225;ria &#233; estimada em 572.000 por ano ou 174% da taxa atual.
<xref rid="JR2100051-3" ref-type="bibr">3</xref>
&#192; medida que o n&#250;mero total de procedimentos prim&#225;rios de ATQ realizados aumenta, o n&#250;mero de cirurgias de revis&#227;o tamb&#233;m deve aumentar significativamente. Em uma proje&#231;&#227;o, os procedimentos de revis&#227;o de ATQ aumentar&#227;o em 2 vezes at&#233; 2026.
<xref rid="JR2100051-3" ref-type="bibr">3</xref>
</p><p>
Se os n&#250;meros da ATQ prim&#225;ria e de revis&#227;o crescerem conforme projetado, o n&#250;mero estimado de casos de ATQ superar&#225; a quantidade estimada de cirurgi&#245;es de artroplastia treinados por bolsas.
<xref rid="JR2100051-3" ref-type="bibr">3</xref>
<xref rid="JR2100051-4" ref-type="bibr">4</xref>
Como resultado, cirurgi&#245;es n&#227;o treinados por bolsas experimentar&#227;o um aumento da demanda para realizar a ATQ prim&#225;ria e a revis&#227;o, exigindo que eles confiem nas habilidades e t&#233;cnicas desenvolvidas durante a resid&#234;ncia.
<xref rid="JR2100051-5" ref-type="bibr">5</xref>
Portanto, os residentes devem ser fornecidos com treinamento de alta qualidade na realiza&#231;&#227;o da ATQ prim&#225;ria e de revis&#227;o.
</p><p>
Os sistemas de sa&#250;de est&#227;o cada vez mais atentos &#224; morbidade e mortalidade p&#243;s-operat&#243;rias, pois as complica&#231;&#245;es podem diminuir a qualidade de vida de um paciente e aumentar a carga financeira sobre hospitais e prestadores de cuidados de sa&#250;de.
<xref rid="JR2100051-2" ref-type="bibr">2</xref>
Como resultado, os sistemas de sa&#250;de est&#227;o implementando iniciativas de controle de qualidade.
<xref rid="JR2100051-6" ref-type="bibr">6</xref>
Os residentes comp&#245;em uma grande fra&#231;&#227;o da equipe de sa&#250;de dentro dos centros acad&#234;micos, e quantificar seu impacto em complica&#231;&#245;es agudas p&#243;s-operat&#243;rias &#233; imperativo. Em cirurgia geral, quantidades consider&#225;veis de literatura t&#234;m tentado quantificar se o envolvimento dos residentes exerce algum efeito prejudicial sobre os desfechos dos procedimentos cir&#250;rgicos, mas os estudos t&#234;m resultados variados.
<xref rid="JR2100051-7" ref-type="bibr">7</xref>
<xref rid="JR2100051-8" ref-type="bibr">8</xref>
<xref rid="JR2100051-9" ref-type="bibr">9</xref>
<xref rid="JR2100051-10" ref-type="bibr">10</xref>
A literatura semelhante para ortopedia n&#227;o &#233; t&#227;o vasta.
<xref rid="JR2100051-11" ref-type="bibr">11</xref>
<xref rid="JR2100051-12" ref-type="bibr">12</xref>
<xref rid="JR2100051-13" ref-type="bibr">13</xref>
<xref rid="JR2100051-14" ref-type="bibr">14</xref>
<xref rid="JR2100051-15" ref-type="bibr">15</xref>
</p><p>
O objetivo do presente estudo foi determinar o impacto do envolvimento dos residentes na revis&#227;o da ATQ utilizando o banco de dados do American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP, na sigla em ingl&#234;s).
<xref rid="OR2100051-16" ref-type="bibr">16</xref>
Foram analisadas as taxas de complica&#231;&#227;o perioperat&#243;ria e p&#243;s-operat&#243;ria para revis&#227;o de casos de ATQ com envolvimento de residentes para discernir se o envolvimento dos residentes est&#225; correlacionado a desfechos ruins dos pacientes.
</p></sec><sec><title>Materiais e M&#233;todos</title><p>O NSQIP foi criado em 2012 para ajudar a entender melhor e melhorar os resultados dos pacientes. Foram coletadas informa&#231;&#245;es cl&#237;nicas e desfechos cir&#250;rgicos de&#8201;&gt;&#8201;400 hospitais em 2012. A variedade de hospitais amostrados incluiu hospitais privados, p&#250;blicos, acad&#234;micos e n&#227;o acad&#234;micos em &#225;reas urbanas e rurais. Os pacientes s&#227;o acompanhados por 30 dias ap&#243;s a cirurgia, e quaisquer complica&#231;&#245;es agudas, reopera&#231;&#245;es ou reinterna&#231;&#245;es s&#227;o registradas. O banco de dados &#233; mantido pelo American College of Surgeons e os dados s&#227;o coletados por um revisor cl&#237;nico cir&#250;rgico treinado.</p></sec><sec><title>Sele&#231;&#227;o de Pacientes</title><p>
Os pacientes inclu&#237;dos no presente estudo observacional retrospectivo apresentaram uma revis&#227;o total da artroplastia do quadril definida pelo c&#243;digo terminol&#243;gico processual atual 27134 (procedimentos de repara&#231;&#227;o, revis&#227;o e/ou reconstru&#231;&#227;o na pelve e articula&#231;&#227;o do quadril) entre 2008 e 2012. O NSQIP registra o envolvimento dos residentes utilizando a vari&#225;vel "PGY" seguida de um n&#250;mero (1 a 6) que identifica ano de treinamento de resid&#234;ncia. O cirurgi&#227;o residente que participou e tem o mais alto n&#237;vel de treinamento foi registrado. Casos que n&#227;o incluem um residente foram registrados com um "0". Foram inclu&#237;dos os n&#237;veis de residentes PGY1-5, enquanto os bolsistas (PGY6) foram exclu&#237;dos. Al&#233;m disso, se o envolvimento do residente n&#227;o foi indicado, o paciente foi exclu&#237;do. A extens&#227;o da participa&#231;&#227;o dos residentes no caso n&#227;o foi explicitamente declarada no NSQIP, mas o n&#237;vel de treinamento foi inclu&#237;do. No total, 1.743 pacientes passaram por revis&#227;o e atenderam aos crit&#233;rios de inclus&#227;o. Destes, 54,4% (
<italic toggle="yes">n</italic>
&#8201;=&#8201;949) foram realizados com envolvimento de residentes.
</p></sec><sec><title>Resultados</title><p>As complica&#231;&#245;es agudas p&#243;s-operat&#243;rias identificadas dentro de 30 dias incluem falha de enxerto/pr&#243;tese/reta, infec&#231;&#227;o no local cir&#250;rgico, desilus&#227;o de feridas, reopera&#231;&#227;o, pneumonia, intuba&#231;&#227;o n&#227;o planejada, trombose venosa profunda (TVP), tromboembolismo pulmonar (TEP), ventila&#231;&#227;o&#8201;&gt;&#8201;48 horas, insufici&#234;ncia renal, insufici&#234;ncia renal aguda, infec&#231;&#227;o do trato urin&#225;rio (ITU), acidente vascular cerebral/cerebrovascular (CVA), les&#227;o nervosa perif&#233;rica, parada card&#237;aca e infarto do mioc&#225;rdio. Tamb&#233;m foi analisado o tempo de perman&#234;ncia e o tempo total de interna&#231;&#227;o no hospital.</p></sec><sec><title>An&#225;lise estat&#237;stica</title><p>A demografia pr&#233;-operat&#243;ria, as comorbidades m&#233;dicas e os desfechos p&#243;s-operat&#243;rios foram comparados entre os casos com e sem envolvimento residente por meio de testes de qui-quadrado de duas laterais e pelo teste de Fisher. As vari&#225;veis relacionadas ao tempo de opera&#231;&#227;o foram ajustadas utilizando-se uma regress&#227;o linear multivari&#225;vel para remover sua influ&#234;ncia potencialmente confusa sobre a associa&#231;&#227;o entre o tempo de opera&#231;&#227;o e o envolvimento do residente. Todos os valores-p &#8804;0,05 foram considerados estatisticamente significativos.</p><p>Todas as an&#225;lises estat&#237;sticas foram realizadas utilizando-se a vers&#227;o 9.4 do software SAS (SAS Institute, Cary, Carolina do Norte).</p></sec><sec><title>Resultados</title></sec><sec><title>Caracter&#237;sticas pr&#233;-operat&#243;rias</title><p>
As caracter&#237;sticas pr&#233;-operat&#243;rias estratificadas de acordo com o envolvimento dos residentes s&#227;o mostradas na
<xref rid="TB2100051pt-1" ref-type="table">Tabela 1</xref>
. As vari&#225;veis que apresentam signific&#226;ncia incluem tipo de anestesia (
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0,001), doen&#231;a pulmonar obstrutiva cr&#244;nica (4,64% residente presente, 6,93% sem residente;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,04), opera&#231;&#227;o pr&#233;via dentro de 30 dias (3,79% residente presente, 6,52% sem residente;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,01), hipertens&#227;o que necessita de medica&#231;&#227;o (55,53% residente presente, 63,98% sem residente;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0,001), estado de diabetes (
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,005) e estado de interna&#231;&#227;o (98,10% residente presente, 99,37% sem residente;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,02).
</p><table-wrap id="TB2100051pt-1" position="float" orientation="portrait"><label>Tabela 1</label><caption><title>Demografia pr&#233;-operat&#243;ria e comorbidades m&#233;dicas estratificadas pelo envolvimento do residente para 1.743 pacientes que tiveram uma revis&#227;o da artroplastia total de quadril registrada no Banco de Dados NSQIP de 2008 a 2012</title></caption><table rules="all"><colgroup align="left" span="4"><col align="left" width="163.55pt" span="1"/><col align="left" width="104.7pt" span="1"/><col align="left" width="104.8pt" span="1"/><col align="left" width="102.7pt" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1"/><th align="left" valign="bottom" colspan="1" rowspan="1">Residente presente, %</th><th align="left" valign="bottom" colspan="1" rowspan="1">Residente n&#227;o presente, %</th><th align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">valor-p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">G&#234;nero</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Feminino</td><td align="left" valign="top" colspan="1" rowspan="1">54,12</td><td align="left" valign="top" colspan="1" rowspan="1">52,33</td><td align="left" rowspan="2" valign="top" colspan="1">0,46</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Masculino</td><td align="left" valign="top" colspan="1" rowspan="1">45,88</td><td align="left" valign="top" colspan="1" rowspan="1">47,67</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Classifica&#231;&#227;o ASA</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 1</td><td align="left" valign="top" colspan="1" rowspan="1">1,48</td><td align="left" valign="top" colspan="1" rowspan="1">1,89</td><td align="left" rowspan="5" valign="top" colspan="1">0,51</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 2</td><td align="left" valign="top" colspan="1" rowspan="1">43,20</td><td align="left" valign="top" colspan="1" rowspan="1">39,80</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 3</td><td align="left" valign="top" colspan="1" rowspan="1">50,47</td><td align="left" valign="top" colspan="1" rowspan="1">53,53</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 4</td><td align="left" valign="top" colspan="1" rowspan="1">4,74</td><td align="left" valign="top" colspan="1" rowspan="1">4,79</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;ASA 5</td><td align="left" valign="top" colspan="1" rowspan="1">0,11</td><td align="left" valign="top" colspan="1" rowspan="1">0</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Ra&#231;a</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#205;ndio americano ou nativo do Alasca</td><td align="left" valign="top" colspan="1" rowspan="1">0,65</td><td align="left" valign="top" colspan="1" rowspan="1">0,41</td><td align="left" rowspan="5" valign="top" colspan="1">0,78</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Asi&#225;tico</td><td align="left" valign="top" colspan="1" rowspan="1">1,04</td><td align="left" valign="top" colspan="1" rowspan="1">0,55</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Negros ou afro-americanos</td><td align="left" valign="top" colspan="1" rowspan="1">6,61</td><td align="left" valign="top" colspan="1" rowspan="1">6,05</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Ilha havaiana ou do Pac&#237;fico nativa</td><td align="left" valign="top" colspan="1" rowspan="1">0,13</td><td align="left" valign="top" colspan="1" rowspan="1">0,14</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Branco</td><td align="left" valign="top" colspan="1" rowspan="1">91,58</td><td align="left" valign="top" colspan="1" rowspan="1">92,85</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Anestesia</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Epidural</td><td align="left" valign="top" colspan="1" rowspan="1">0,21</td><td align="left" valign="top" colspan="1" rowspan="1">1,01</td><td align="left" rowspan="7" valign="top" colspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Geral</td><td align="left" valign="top" colspan="1" rowspan="1">74,71</td><td align="left" valign="top" colspan="1" rowspan="1">73,17</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Seda&#231;&#227;o MAC /Intravenosa</td><td align="left" valign="top" colspan="1" rowspan="1">0,53</td><td align="left" valign="top" colspan="1" rowspan="1">0</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cuidados de anestesia monitorada</td><td align="left" valign="top" colspan="1" rowspan="1">0,11</td><td align="left" valign="top" colspan="1" rowspan="1">0,13</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Regional</td><td align="left" valign="top" colspan="1" rowspan="1">8,96</td><td align="left" valign="top" colspan="1" rowspan="1">1,89</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Espinal</td><td align="left" valign="top" colspan="1" rowspan="1">15,28</td><td align="left" valign="top" colspan="1" rowspan="1">23,80</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Desconhecido</td><td align="left" valign="top" colspan="1" rowspan="1">0,21</td><td align="left" valign="top" colspan="1" rowspan="1">0</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Doen&#231;a pulmonar obstrutiva cr&#244;nica</td><td align="left" valign="top" colspan="1" rowspan="1">4,64</td><td align="left" valign="top" colspan="1" rowspan="1">6,93</td><td align="left" valign="top" colspan="1" rowspan="1">0,04</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Insufici&#234;ncia card&#237;aca congestiva dentro de 30 dias antes da cirurgia</td><td align="left" valign="top" colspan="1" rowspan="1">0,74</td><td align="left" valign="top" colspan="1" rowspan="1">0,88</td><td align="left" valign="top" colspan="1" rowspan="1">0,79</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hist&#243;rico de infarto do mioc&#225;rdio 6 meses antes da cirurgia</td><td align="left" valign="top" colspan="1" rowspan="1">0,53</td><td align="left" valign="top" colspan="1" rowspan="1">0,26</td><td align="left" valign="top" colspan="1" rowspan="1">0,46</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hist&#243;rico de angina 1 m&#234;s antes da cirurgia</td><td align="left" valign="top" colspan="1" rowspan="1">0,63</td><td align="left" valign="top" colspan="1" rowspan="1">0,39</td><td align="left" valign="top" colspan="1" rowspan="1">0,52</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Insufici&#234;ncia renal aguda, p&#243;s-operat&#243;ria</td><td align="left" valign="top" colspan="1" rowspan="1">0,11</td><td align="left" valign="top" colspan="1" rowspan="1">0,25</td><td align="left" valign="top" colspan="1" rowspan="1">0,59</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Interven&#231;&#227;o coron&#225;ria percut&#226;nea anterior</td><td align="left" valign="top" colspan="1" rowspan="1">7,17</td><td align="left" valign="top" colspan="1" rowspan="1">7,47</td><td align="left" valign="top" colspan="1" rowspan="1">0,85</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">EtOH &#8201;&gt;&#8201;2 bebidas/dia em 2 semanas antes da admiss&#227;o</td><td align="left" valign="top" colspan="1" rowspan="1">4,11</td><td align="left" valign="top" colspan="1" rowspan="1">3,22</td><td align="left" valign="top" colspan="1" rowspan="1">0,37</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Cirurgia card&#237;aca anterior</td><td align="left" valign="top" colspan="1" rowspan="1">6,32</td><td align="left" valign="top" colspan="1" rowspan="1">6,57</td><td align="left" valign="top" colspan="1" rowspan="1">0,84</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hist&#243;rico de revasculariza&#231;&#227;o/amputa&#231;&#227;o de doen&#231;a vascular perif&#233;rica</td><td align="left" valign="top" colspan="1" rowspan="1">0,53</td><td align="left" valign="top" colspan="1" rowspan="1">1,29</td><td align="left" valign="top" colspan="1" rowspan="1">0,11</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Atualmente em di&#225;lise, pr&#233;-operat&#243;ria</td><td align="left" valign="top" colspan="1" rowspan="1">0,32</td><td align="left" valign="top" colspan="1" rowspan="1">0,63</td><td align="left" valign="top" colspan="1" rowspan="1">0,48</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hist&#243;rico de ataques isqu&#234;micos transit&#243;rios</td><td align="left" valign="top" colspan="1" rowspan="1">3,37</td><td align="left" valign="top" colspan="1" rowspan="1">3,48</td><td align="left" valign="top" colspan="1" rowspan="1">0,89</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Acidente vascular cerebral/acidente cerebrovascular com d&#233;ficit neurol&#243;gico</td><td align="left" valign="top" colspan="1" rowspan="1">2,32</td><td align="left" valign="top" colspan="1" rowspan="1">2,19</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Acidente vascular cerebral/acidente cerebrovascular sem d&#233;ficit neurol&#243;gico</td><td align="left" valign="top" colspan="1" rowspan="1">3,07</td><td align="left" valign="top" colspan="1" rowspan="1">3,22</td><td align="left" valign="top" colspan="1" rowspan="1">0,89</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Paraplegia</td><td align="left" valign="top" colspan="1" rowspan="1">0,32</td><td align="left" valign="top" colspan="1" rowspan="1">0,26</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hemiplegia</td><td align="left" valign="top" colspan="1" rowspan="1">0,95</td><td align="left" valign="top" colspan="1" rowspan="1">0,64</td><td align="left" valign="top" colspan="1" rowspan="1">0,59</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Quadriplegia</td><td align="left" valign="top" colspan="1" rowspan="1">0,21</td><td align="left" valign="top" colspan="1" rowspan="1">0</td><td align="left" valign="top" colspan="1" rowspan="1">0,50</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Quimioterapia para malignidade &#8804; 30 dias antes da revis&#227;o da artroplastia total do quadril</td><td align="left" valign="top" colspan="1" rowspan="1">0,53</td><td align="left" valign="top" colspan="1" rowspan="1">0,39</td><td align="left" valign="top" colspan="1" rowspan="1">0,73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">C&#226;ncer disseminado</td><td align="left" valign="top" colspan="1" rowspan="1">0,42</td><td align="left" valign="top" colspan="1" rowspan="1">1,01</td><td align="left" valign="top" colspan="1" rowspan="1">0,15</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Uso de esteroides para condi&#231;&#227;o cr&#244;nica</td><td align="left" valign="top" colspan="1" rowspan="1">6,22</td><td align="left" valign="top" colspan="1" rowspan="1">4,53</td><td align="left" valign="top" colspan="1" rowspan="1">0,13</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Perda de peso corporal&#8201;&gt;&#8201;10% nos &#250;ltimos 6 meses</td><td align="left" valign="top" colspan="1" rowspan="1">0,63</td><td align="left" valign="top" colspan="1" rowspan="1">1,26</td><td align="left" valign="top" colspan="1" rowspan="1">0,21</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Dist&#250;rbios hemorr&#225;gicos</td><td align="left" valign="top" colspan="1" rowspan="1">5,90</td><td align="left" valign="top" colspan="1" rowspan="1">6,05</td><td align="left" valign="top" colspan="1" rowspan="1">0,91</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Opera&#231;&#227;o anterior dentro de 30 dias</td><td align="left" valign="top" colspan="1" rowspan="1">3,79</td><td align="left" valign="top" colspan="1" rowspan="1">6,52</td><td align="left" valign="top" colspan="1" rowspan="1">0,01</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Hipertens&#227;o que requer medica&#231;&#227;o</td><td align="left" valign="top" colspan="1" rowspan="1">55,53</td><td align="left" valign="top" colspan="1" rowspan="1">63,98</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Fumante atual dentro de 1 ano</td><td align="left" valign="top" colspan="1" rowspan="1">15,38</td><td align="left" valign="top" colspan="1" rowspan="1">14,74</td><td align="left" valign="top" colspan="1" rowspan="1">0,73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Estado de diabetes</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus com insulina</td><td align="left" valign="top" colspan="1" rowspan="1">3,37</td><td align="left" valign="top" colspan="1" rowspan="1">3,78</td><td align="left" rowspan="4" valign="top" colspan="1">0,005</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus sem agentes orais ou insulina</td><td align="left" valign="top" colspan="1" rowspan="1">87,46</td><td align="left" valign="top" colspan="1" rowspan="1">87,15</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus com agentes n&#227;o orais e n&#227;o-insulina</td><td align="left" valign="top" colspan="1" rowspan="1">6,95</td><td align="left" valign="top" colspan="1" rowspan="1">4,41</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Diabetes mellitus com agentes orais</td><td align="left" valign="top" colspan="1" rowspan="1">2,21</td><td align="left" valign="top" colspan="1" rowspan="1">4,66</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Estado de sa&#250;de funcional antes da cirurgia</td><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/><td align="left" valign="top" colspan="1" rowspan="1"/></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Independente</td><td align="left" valign="top" colspan="1" rowspan="1">85,46</td><td align="left" valign="top" colspan="1" rowspan="1">84,13</td><td align="left" rowspan="4" valign="top" colspan="1">0,08</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Parcialmente dependente</td><td align="left" valign="top" colspan="1" rowspan="1">13,49</td><td align="left" valign="top" colspan="1" rowspan="1">13,22</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Totalmente dependente</td><td align="left" valign="top" colspan="1" rowspan="1">1,05</td><td align="left" valign="top" colspan="1" rowspan="1">2,52</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Desconhecido</td><td align="left" valign="top" colspan="1" rowspan="1">0</td><td align="left" valign="top" colspan="1" rowspan="1">0,13</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Interna&#231;&#227;o</td><td align="left" valign="top" colspan="1" rowspan="1">98,10</td><td align="left" valign="top" colspan="1" rowspan="1">99,37</td><td align="left" valign="top" colspan="1" rowspan="1">0,02</td></tr></tbody></table><table-wrap-foot><fn id="FN2100051pt-2"><p>Abrevia&#231;&#245;es: ASA, Sociedade Americana de Anestesiologistas</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Tempo operacional total e tempo de perman&#234;ncia</title><p>
Compara&#231;&#245;es univariadas de taxas de complica&#231;&#245;es entre os procedimentos de revis&#227;o de ATQ com e sem o envolvimento de um residente s&#227;o mostradas na
<xref rid="TB2100051pt-2" ref-type="table">Tabela 2</xref>
. Houve aumento significativo no tempo total de opera&#231;&#227;o com envolvimento de residente versus sem residente (161,35 minutos residente presente, 135,07 minutos sem residente;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0,001). O tempo de perman&#234;ncia (em dias) n&#227;o foi significativamente aumentado (5,61 dias residente presente, 5,22 dias sem residente;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,46).
</p><table-wrap id="TB2100051pt-2" position="float" orientation="portrait"><label>Tabela 2</label><caption><title>Taxas de complica&#231;&#245;es, tempo de perman&#234;ncia e tempo de opera&#231;&#227;o total estratificado por envolvimento do residente para 1.743 pacientes que tiveram uma revis&#227;o da artroplastia total de quadril registrada no banco de dados NSQIP de 2008 a 2012</title></caption><table rules="all"><colgroup align="left" span="4"><col align="left" width="124.1pt" span="1"/><col align="left" width="114.6pt" span="1"/><col align="left" width="114.65pt" span="1"/><col align="left" width="114.15pt" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1"/><th align="left" valign="bottom" colspan="1" rowspan="1">
Residente presente (
<italic toggle="yes">n</italic>
&#8201;=&#8201;
<italic toggle="yes">949</italic>
)
</th><th align="left" valign="bottom" colspan="1" rowspan="1">
Residente n&#227;o presente (
<italic toggle="yes">n</italic>
&#8201;=&#8201;794)
</th><th align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">valor-p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Tempo de opera&#231;&#227;o, minutos</td><td align="left" valign="top" colspan="1" rowspan="1">161,35</td><td align="left" valign="top" colspan="1" rowspan="1">135,07</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Tempo de perman&#234;ncia, dias</td><td align="left" valign="top" colspan="1" rowspan="1">5,61</td><td align="left" valign="top" colspan="1" rowspan="1">5,22</td><td align="left" valign="top" colspan="1" rowspan="1">0,46</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">
Complica&#231;&#245;es p&#243;s-operat&#243;rias agudas,
<italic toggle="yes">n</italic>
, (%)
</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Falha de enxerto/pr&#243;tese/ Falha de retalho</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0,53)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,50)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Infec&#231;&#227;o superficial</td><td align="left" valign="top" colspan="1" rowspan="1">9 (0,95)</td><td align="left" valign="top" colspan="1" rowspan="1">11 (1,39)</td><td align="left" valign="top" colspan="1" rowspan="1">0,49</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Infec&#231;&#227;o Profunda</td><td align="left" valign="top" colspan="1" rowspan="1">12 (1,26)</td><td align="left" valign="top" colspan="1" rowspan="1">16 (2,02)</td><td align="left" valign="top" colspan="1" rowspan="1">0,25</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Deisc&#234;ncia da ferida</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,42)</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0,63)</td><td align="left" valign="top" colspan="1" rowspan="1">0,73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Reopera&#231;&#227;o</td><td align="left" valign="top" colspan="1" rowspan="1">61 (6,43)</td><td align="left" valign="top" colspan="1" rowspan="1">58 (7,30)</td><td align="left" valign="top" colspan="1" rowspan="1">0,50</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Pneumonia</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,42)</td><td align="left" valign="top" colspan="1" rowspan="1">6 (0,76)</td><td align="left" valign="top" colspan="1" rowspan="1">0,52</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Intuba&#231;&#227;o n&#227;o planejada</td><td align="left" valign="top" colspan="1" rowspan="1">6 (0,63)</td><td align="left" valign="top" colspan="1" rowspan="1">7 (0,88)</td><td align="left" valign="top" colspan="1" rowspan="1">0,58</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Trombose venosa profunda</td><td align="left" valign="top" colspan="1" rowspan="1">7 (0,74)</td><td align="left" valign="top" colspan="1" rowspan="1">7 (0,88)</td><td align="left" valign="top" colspan="1" rowspan="1">0,79</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Embolia Pulmonar</td><td align="left" valign="top" colspan="1" rowspan="1">1 (0,11)</td><td align="left" valign="top" colspan="1" rowspan="1">1 (0,13)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Ventila&#231;&#227;o&#8201;&gt;&#8201;48 horas</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,42)</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0,63)</td><td align="left" valign="top" colspan="1" rowspan="1">0 0,73</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Insufici&#234;ncia renal</td><td align="left" valign="top" colspan="1" rowspan="1">3 (0,32)</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0,25)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Insufici&#234;ncia renal aguda</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0,21)</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0,25)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Infec&#231;&#227;o do trato urin&#225;rio</td><td align="left" valign="top" colspan="1" rowspan="1">19 (2,00)</td><td align="left" valign="top" colspan="1" rowspan="1">16 (2,02)</td><td align="left" valign="top" colspan="1" rowspan="1">&gt; 0,99</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Acidente vascular cerebral/cerebrovascular</td><td align="left" valign="top" colspan="1" rowspan="1">2 (0,21)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,50)</td><td align="left" valign="top" colspan="1" rowspan="1">0,42</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Les&#227;o do nervo perif&#233;rico</td><td align="left" valign="top" colspan="1" rowspan="1">6 (0,63)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,50)</td><td align="left" valign="top" colspan="1" rowspan="1">0,76</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Parada card&#237;aca</td><td align="left" valign="top" colspan="1" rowspan="1">3 (0,32)</td><td align="left" valign="top" colspan="1" rowspan="1">4 (0,50)</td><td align="left" valign="top" colspan="1" rowspan="1">0,70</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#8195;Infarto do mioc&#225;rdio</td><td align="left" valign="top" colspan="1" rowspan="1">9 (0,95)</td><td align="left" valign="top" colspan="1" rowspan="1">5 (0,63)</td><td align="left" valign="top" colspan="1" rowspan="1">0,59</td></tr></tbody></table></table-wrap></sec><sec><title>Complica&#231;&#245;es agudas p&#243;s-operat&#243;rias</title><p>A maioria das taxas de complica&#231;&#245;es diminuiu com um residente presente, embora n&#227;o tenham alcan&#231;ado signific&#226;ncia.</p></sec><sec><title>Modelo de regress&#227;o multivari&#225;vel / Fatores de Risco</title><p>
Resultados significativos do modelo de regress&#227;o para os tempos operacionais s&#227;o mostrados na
<xref rid="TB2100051pt-3" ref-type="table">Tabela 3</xref>
. O tempo de opera&#231;&#227;o aumentou 28,41 minutos com o envolvimento dos residentes (
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0,001). Pacientes identificados como negros ou afro-americanos apresentaram tempos de opera&#231;&#227;o mais longos (+ 10,79 minutos;
<italic toggle="yes">p</italic>
&#8201;=&#8201;0,02).
</p><table-wrap id="TB2100051pt-3" position="float" orientation="portrait"><label>Tabela 3</label><caption><title>An&#225;lise de regress&#227;o multivari&#225;vel com tempo operacional total como vari&#225;vel dependente para 1.743 pacientes que tiveram uma revis&#227;o da artroplastia total de quadril registrada no banco de dados NSQIP de 2008-2012</title></caption><table rules="all"><colgroup align="left" span="3"><col align="left" width="247.25pt" span="1"/><col align="left" width="112.5pt" span="1"/><col align="left" width="99.35pt" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" colspan="1" rowspan="1">Covariadas</th><th align="left" valign="bottom" colspan="1" rowspan="1">Mudan&#231;a no tempo de opera&#231;&#227;o, minutos</th><th align="left" valign="bottom" colspan="1" rowspan="1">
<italic toggle="yes">valor-p</italic>
</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">G&#234;nero &#8211; Feminino</td><td align="left" valign="top" colspan="1" rowspan="1">-11,13</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Classifica&#231;&#227;o ASA 1</td><td align="left" valign="top" colspan="1" rowspan="1">- 23,96</td><td align="left" valign="top" colspan="1" rowspan="1">0,03</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Classifica&#231;&#227;o ASA 2</td><td align="left" valign="top" colspan="1" rowspan="1">- 9,44</td><td align="left" valign="top" colspan="1" rowspan="1">0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Ra&#231;a &#8211; negro ou afro-americano</td><td align="left" valign="top" colspan="1" rowspan="1">10,79</td><td align="left" valign="top" colspan="1" rowspan="1">0,02</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Anestesia &#8211; regional</td><td align="left" valign="top" colspan="1" rowspan="1">- 38,47</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Anestesia - espinhal</td><td align="left" valign="top" colspan="1" rowspan="1">- 19,947</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Interven&#231;&#227;o coron&#225;ria percut&#226;nea anterior &#8211; Sim</td><td align="left" valign="top" colspan="1" rowspan="1">- 10,093</td><td align="left" valign="top" colspan="1" rowspan="1">0,03</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Opera&#231;&#227;o pr&#233;via at&#233; 30 dias antes - sim</td><td align="left" valign="top" colspan="1" rowspan="1">- 23,460</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Fumante atual dentro de 1 ano - sim</td><td align="left" valign="top" colspan="1" rowspan="1">- 9,958</td><td align="left" valign="top" colspan="1" rowspan="1">0,01</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Ambulatorial</td><td align="left" valign="top" colspan="1" rowspan="1">- 40,224</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Residente presente</td><td align="left" valign="top" colspan="1" rowspan="1">28,412</td><td align="left" valign="top" colspan="1" rowspan="1">&lt; 0,001</td></tr></tbody></table></table-wrap><p>
As vari&#225;veis que apresentaram menor tempo de procedimento inclu&#237;ram pacientes do sexo feminino, classifica&#231;&#227;o ASA de 1 ou 2, interven&#231;&#227;o coron&#225;ria percut&#226;nea anterior (ICP), opera&#231;&#227;o pr&#233;via no prazo de 30 dias antes da ATQ, ser fumante ativo e ser paciente ambulatorial. As cirurgias que utilizaram anestesia espinhal ou regional foram significativamente mais curtas do que as cirurgias utilizando os outros tipos de anestesia. (-19,94 minutos e - 38.471 minutos, respectivamente;
<italic toggle="yes">p</italic>
&#8201;&lt;&#8201;0,001 para ambos).
</p></sec><sec><title>An&#225;lise de Pot&#234;ncia</title><p>Para todas as compara&#231;&#245;es, exceto tempo de centro cir&#250;rgico, a pot&#234;ncia &#233; inferior a 10%. A pot&#234;ncia para o tempo de centro cir&#250;rgico &#233; de 99%.</p></sec><sec><title>Discuss&#227;o</title><p>
O envolvimento dos residentes na revis&#227;o da ATQ n&#227;o aumenta significativamente as complica&#231;&#245;es agudas p&#243;s-operat&#243;rias dentro de 30 dias. O presente estudo de um grande banco de dados nacional de 1.743 casos constatou que o tempo de opera&#231;&#227;o aumentou em m&#233;dia 28,41 minutos. Apesar deste aumento no tempo de opera&#231;&#227;o, o n&#250;mero de complica&#231;&#245;es agudas p&#243;s-operat&#243;rias foi baixo em ambas as coortes de pacientes. Isto destaca a seguran&#231;a geral e a efic&#225;cia dos procedimentos de revis&#227;o de artroplastia do quadril. O aumento do tempo de opera&#231;&#227;o observado com a participa&#231;&#227;o dos residentes n&#227;o levou a um aumento associado de infec&#231;&#245;es superficiais (0,95
<italic toggle="yes">versus</italic>
1,39%), infec&#231;&#245;es profundas (0,46
<italic toggle="yes">versus</italic>
0,93%) ou deisc&#234;ncia de feridas (0,42
<italic toggle="yes">versus</italic>
0,63%).
</p><p>
Espera-se que os n&#250;meros de casos de ATQ prim&#225;ria e de revis&#227;o superem o n&#250;mero estimado de cirurgi&#245;es conjuntos treinados por bolsas.
<xref rid="JR2100051-4" ref-type="bibr">4</xref>
&#192; medida que isso ocorrer, os cirurgi&#245;es ortop&#233;dicos n&#227;o treinados ser&#227;o incentivados a arcar com a demanda extra, se estiverem devidamente treinados, destacando o valor de envolver os residentes em casos de artroplastia do quadril. &#201; importante, ent&#227;o, entender o impacto que eles t&#234;m nos resultados dos pacientes. Os residentes n&#227;o influenciam as taxas de complica&#231;&#245;es na ATQ prim&#225;ria,
<xref rid="JR2100051-5" ref-type="bibr">5</xref>
<xref rid="JR2100051-15" ref-type="bibr">15</xref>
mas a revis&#227;o de ATQ &#233; mais complexa e produz diferentes desafios com novas oportunidades de complica&#231;&#245;es.
</p></sec><sec><title>Estudos pr&#233;vios sobre o envolvimento de residentes</title><p>
A morbidade de maior n&#250;mero n&#227;o aumentou com o envolvimento dos residentes em 66.817 casos envolvendo 6 procedimentos ortop&#233;dicos diferentes (estratifica&#231;&#227;o para a gravidade da morbidade).
<xref rid="JR2100051-17" ref-type="bibr">17</xref>
A influ&#234;ncia dos residentes na morbidade menor, no entanto, &#233; dif&#237;cil de isolar devido &#224; alta carga de doen&#231;as nos pacientes e ao envolvimento de numerosos funcion&#225;rios no p&#243;s-operat&#243;rio. Os dados do NSQIP de 2005 a 2010 revelaram que os residentes aumentam significativamente o risco de &#8805; 1complica&#231;&#245;es p&#243;s-operat&#243;rias ou complica&#231;&#245;es sist&#234;micas graves na artroplastia total do joelho e da articula&#231;&#227;o do quadril.
<xref rid="JR2100051-11" ref-type="bibr">11</xref>
Este estudo n&#227;o estratificou o total de casos de artroplastia total do joelho e do quadril em coortes separadas. Em contrapartida, um segundo estudo revelou que os residentes n&#227;o influenciam em complica&#231;&#245;es nos casos prim&#225;rios de ATQ, mas as cirurgias de revis&#227;o foram exclu&#237;das na an&#225;lise (dados do NSQIP de 2012).
<xref rid="JR2100051-5" ref-type="bibr">5</xref>
Uma vez que as revis&#245;es de ATQs s&#227;o procedimentos mais exigentes, os dados limitados aos procedimentos prim&#225;rios de ATQ n&#227;o categorizam com precis&#227;o o envolvimento dos residentes nas revis&#245;es.
<xref rid="JR2100051-18" ref-type="bibr">18</xref>
<xref rid="JR2100051-19" ref-type="bibr">19</xref>
<xref rid="JR2100051-20" ref-type="bibr">20</xref>
O presente estudo n&#227;o apresentou aumento de complica&#231;&#245;es maiores ou menores com o envolvimento dos residentes durante a revis&#227;o dos casos de ATQ.
</p></sec><sec><title>Desafios da Revis&#227;o de ATQ</title><p>
As ATQs prim&#225;rias reduzem a dor de forma confi&#225;vel e aumentam o estado funcional para pacientes com osteoartrite em est&#225;gio final. Por meio da interven&#231;&#227;o operat&#243;ria precoce, os pacientes podem alcan&#231;ar excelentes resultados, e a taxa de cirurgia de revis&#227;o permanece baixa, em 6% aos 5 anos e em 12% aos 10 anos.
<xref rid="JR2100051-21" ref-type="bibr">21</xref>
<xref rid="JR2100051-22" ref-type="bibr">22</xref>
Apesar das altas taxas de sucesso e dos benef&#237;cios da ATQ prim&#225;ria, a luxa&#231;&#227;o e a infec&#231;&#227;o ainda podem levar &#224; falha e &#224; revis&#227;o do implante.
<xref rid="JR2100051-4" ref-type="bibr">4</xref>
A anatomia distorcida e as complica&#231;&#245;es associadas &#224; ATQ prim&#225;ria podem criar desafios &#250;nicos para cirurgi&#245;es ortop&#233;dicos durante a revis&#227;o.
<xref rid="JR2100051-20" ref-type="bibr">20</xref>
<xref rid="JR2100051-23" ref-type="bibr">23</xref>
<xref rid="JR2100051-24" ref-type="bibr">24</xref>
Estes desafios podem levar a um aumento das taxas de mortalidade, de infec&#231;&#227;o e de luxa&#231;&#227;o no p&#243;s-operat&#243;rio em casos de revis&#227;o em compara&#231;&#227;o com a ATQ prim&#225;ria.
<xref rid="JR2100051-25" ref-type="bibr">25</xref>
Al&#233;m disso, os pacientes submetidos &#224; revis&#227;o de ATQ t&#234;m danos &#243;sseos e em tecidos moles ao redor do quadril, o que compromete a articula&#231;&#227;o e, muitas vezes, inibe o uso de implantes prim&#225;rios padr&#227;o.
<xref rid="JR2100051-20" ref-type="bibr">20</xref>
<xref rid="JR2100051-23" ref-type="bibr">23</xref>
<xref rid="JR2100051-24" ref-type="bibr">24</xref>
&#201; fundamental que os cirurgi&#245;es sejam treinados e competentes ao utilizar implantes espec&#237;ficos projetados para trabalhar efetivamente em condi&#231;&#245;es prec&#225;rias.
</p></sec><sec><title>Efeitos do Envolvimento dos Residentes</title><p>
O presente estudo mostrou que as taxas de complica&#231;&#245;es como reopera&#231;&#227;o, TVP e intuba&#231;&#227;o n&#227;o planejada diminu&#237;ram com os residentes envolvidos na revis&#227;o da ATQ. Infec&#231;&#227;o (incluindo infec&#231;&#245;es superficiais, infec&#231;&#245;es profundas e deisc&#234;ncia de feridas), que &#233; causa mais comum de falha na revis&#227;o da ATQ,
<xref rid="JR2100051-26" ref-type="bibr">26</xref>
diminuiu quando os residentes estavam envolvidos. Al&#233;m disso, o envolvimento dos residentes pode ajudar a aumentar a sua confian&#231;a e seu preparo &#224; medida que avan&#231;am na sua carreira.
<xref rid="JR2100051-27" ref-type="bibr">27</xref>
</p><p>
Apesar das taxas de complica&#231;&#245;es n&#227;o aumentarem significativamente com o envolvimento dos residentes, houve um aumento significativo no tempo de opera&#231;&#227;o. Isso pode decorrer do desafio de ensin&#225;-los sobre anatomia complicada, especialmente visto em pacientes com maiores taxas de comorbidades. Este achado j&#225; foi destacado anteriormente em cirurgia geral e em outras especialidades cir&#250;rgicas.
<xref rid="JR2100051-28" ref-type="bibr">28</xref>
<xref rid="JR2100051-29" ref-type="bibr">29</xref>
Embora o aumento do tempo de opera&#231;&#227;o aumente o risco de infec&#231;&#227;o na artroplastia articular prim&#225;ria,
<xref rid="JR2100051-30" ref-type="bibr">30</xref>
o envolvimento dos residentes n&#227;o resultou em aumento de infec&#231;&#245;es.
</p><p>Como esperado, pacientes de menor risco com menos comorbidades, classifica&#231;&#245;es ASA 1 e 2 e procedimentos ambulatoriais, estiveram associados a tempos de opera&#231;&#227;o significativamente menores. O uso da raquigrafia e da anestesia regional, em vez de anestesia geral, tamb&#233;m esteve associado a tempos operacionais mais curtos. Surpreendentemente, mulheres, pacientes com hist&#243;rico de ICP anterior, opera&#231;&#227;o pr&#233;via dentro de 30 dias e tabagismo tamb&#233;m experimentaram tempos operacionais significativamente menores.</p></sec><sec><title>Pontos fortes e limita&#231;&#245;es</title><p>O presente estudo utilizou o banco de dados NSQIP. Trata-se de um grande banco de dados que permite o acesso a uma grande amostra multic&#234;ntrica e multirregional de procedimentos de revis&#227;o de ATQ que notam especificamente o envolvimento dos residentes. No entanto, o uso deste banco de dados vem com desvantagens. Extrapolar dados de v&#225;rios centros m&#233;dicos nos Estados Unidos se presta a um m&#233;todo n&#227;o padronizado de relatar dados. N&#227;o h&#225; nenhum marcador quantificando o grau de envolvimento dos residentes ou a complexidade do caso. Os dados foram coletados por um revisor cir&#250;rgico treinado. Nem o envolvimento relativo do residente nem do cirurgi&#227;o assistente nas etapas cir&#250;rgicas foi quantificado nos registros de dados. N&#227;o &#233; poss&#237;vel isolar o envolvimento dos residentes ortop&#233;dicos, controlando para outros residentes o envolvimento no atendimento ao paciente. O banco de dados s&#243; coleta resultados dentro de 30 dias de cirurgia para que outros desfechos de longo prazo n&#227;o sejam registrados. Al&#233;m disso, n&#227;o foi conclu&#237;da uma an&#225;lise de pot&#234;ncia para garantir o tamanho adequado da amostra.</p><p>Apesar destas limita&#231;&#245;es, este &#233; o maior estudo que avalia o impacto do envolvimento dos residentes em complica&#231;&#245;es agudas p&#243;s-operat&#243;rias para revis&#227;o de ATQ. Foram avaliadas 1.743 revis&#245;es de ATQs, com 794 delas envolvendo m&#233;dicos residentes. No futuro, estudos adicionais grandes, multic&#234;ntricos e prospectivos sobre o envolvimento dos residentes poderiam apoiar os achados do presente estudo.</p></sec><sec><title>Conclus&#245;es</title><p>No geral, o presente estudo mostrou que o envolvimento dos residentes na revis&#227;o n&#227;o impactou significativamente os desfechos, incluindo morbidade, mortalidade e taxas de complica&#231;&#245;es. A participa&#231;&#227;o dos residentes est&#225; associada ao aumento significativo do tempo de opera&#231;&#227;o, mas isto n&#227;o se traduziu em um aumento na taxa de infec&#231;&#227;o. Com base nestes resultados, os residentes devem continuar envolvidos no manejo cir&#250;rgico da revis&#227;o de pacientes com artroplastia total do quadril.</p></sec></body></sub-article></article></pmc-articleset>